US10741034B2 - Security system and method of marking an inventory item and/or person in the vicinity - Google Patents
Security system and method of marking an inventory item and/or person in the vicinity Download PDFInfo
- Publication number
- US10741034B2 US10741034B2 US14/570,242 US201414570242A US10741034B2 US 10741034 B2 US10741034 B2 US 10741034B2 US 201414570242 A US201414570242 A US 201414570242A US 10741034 B2 US10741034 B2 US 10741034B2
- Authority
- US
- United States
- Prior art keywords
- smoke
- nucleic acid
- dna
- taggant
- fog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000000034 method Methods 0.000 title claims abstract description 137
- 108020004414 DNA Proteins 0.000 claims abstract description 407
- 102000053602 DNA Human genes 0.000 claims abstract description 405
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 238
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 220
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 220
- 239000003550 marker Substances 0.000 claims abstract description 141
- 239000012530 fluid Substances 0.000 claims abstract description 68
- 230000003213 activating effect Effects 0.000 claims abstract description 7
- 238000001514 detection method Methods 0.000 claims description 83
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000012408 PCR amplification Methods 0.000 claims description 18
- 238000003753 real-time PCR Methods 0.000 claims description 17
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000000779 smoke Substances 0.000 abstract description 223
- 230000003287 optical effect Effects 0.000 abstract description 52
- 239000000758 substrate Substances 0.000 abstract description 51
- 230000027455 binding Effects 0.000 abstract description 29
- 239000004509 smoke generator Substances 0.000 abstract description 21
- 238000002156 mixing Methods 0.000 abstract description 19
- 239000012670 alkaline solution Substances 0.000 abstract description 18
- 230000004913 activation Effects 0.000 abstract description 10
- 230000003100 immobilizing effect Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 125
- 238000003752 polymerase chain reaction Methods 0.000 description 67
- 239000000975 dye Substances 0.000 description 46
- 239000000243 solution Substances 0.000 description 40
- 239000002585 base Substances 0.000 description 39
- 108091093088 Amplicon Proteins 0.000 description 27
- 239000002245 particle Substances 0.000 description 25
- 230000000295 complement effect Effects 0.000 description 22
- 239000000463 material Substances 0.000 description 22
- 239000002773 nucleotide Substances 0.000 description 22
- 125000003729 nucleotide group Chemical group 0.000 description 22
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 18
- 238000009396 hybridization Methods 0.000 description 17
- 239000003921 oil Substances 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000004744 fabric Substances 0.000 description 15
- -1 polypropylene Polymers 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- 238000005251 capillar electrophoresis Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000007850 fluorescent dye Substances 0.000 description 11
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 10
- 239000002853 nucleic acid probe Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000003321 amplification Effects 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 238000002372 labelling Methods 0.000 description 8
- 239000004005 microsphere Substances 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 229920002477 rna polymer Polymers 0.000 description 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 7
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 239000006174 pH buffer Substances 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 210000002268 wool Anatomy 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 108091092878 Microsatellite Proteins 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 150000001340 alkali metals Chemical class 0.000 description 5
- 235000011089 carbon dioxide Nutrition 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 239000000919 ceramic Substances 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 4
- ACERFIHBIWMFOR-UHFFFAOYSA-N 2-hydroxy-3-[(1-hydroxy-2-methylpropan-2-yl)azaniumyl]propane-1-sulfonate Chemical compound OCC(C)(C)NCC(O)CS(O)(=O)=O ACERFIHBIWMFOR-UHFFFAOYSA-N 0.000 description 4
- INEWUCPYEUEQTN-UHFFFAOYSA-N 3-(cyclohexylamino)-2-hydroxy-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CNC1CCCCC1 INEWUCPYEUEQTN-UHFFFAOYSA-N 0.000 description 4
- XNPKNHHFCKSMRV-UHFFFAOYSA-N 4-(cyclohexylamino)butane-1-sulfonic acid Chemical group OS(=O)(=O)CCCCNC1CCCCC1 XNPKNHHFCKSMRV-UHFFFAOYSA-N 0.000 description 4
- 229930024421 Adenine Natural products 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- PJWWRFATQTVXHA-UHFFFAOYSA-N Cyclohexylaminopropanesulfonic acid Chemical compound OS(=O)(=O)CCCNC1CCCCC1 PJWWRFATQTVXHA-UHFFFAOYSA-N 0.000 description 4
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 108091028664 Ribonucleotide Proteins 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 239000005547 deoxyribonucleotide Substances 0.000 description 4
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
- 238000005108 dry cleaning Methods 0.000 description 4
- 231100000640 hair analysis Toxicity 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 4
- 238000007901 in situ hybridization Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 239000002336 ribonucleotide Substances 0.000 description 4
- 125000002652 ribonucleotide group Chemical group 0.000 description 4
- 238000007790 scraping Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 238000010222 PCR analysis Methods 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229920002988 biodegradable polymer Polymers 0.000 description 3
- 239000004621 biodegradable polymer Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 3
- 150000005829 chemical entities Chemical class 0.000 description 3
- 229940104302 cytosine Drugs 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000008393 encapsulating agent Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 229920000831 ionic polymer Polymers 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
- 239000008000 CHES buffer Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 229920000877 Melamine resin Polymers 0.000 description 2
- 229940126655 NDI-034858 Drugs 0.000 description 2
- 241000290929 Nimbus Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000004697 Polyetherimide Substances 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 239000004734 Polyphenylene sulfide Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- UMIVXZPTRXBADB-UHFFFAOYSA-N benzocyclobutene Chemical compound C1=CC=C2CCC2=C1 UMIVXZPTRXBADB-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 229910052792 caesium Inorganic materials 0.000 description 2
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 229920005669 high impact polystyrene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- 239000004797 high-impact polystyrene Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000009830 intercalation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 229920001568 phenolic resin Polymers 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001601 polyetherimide Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920000069 polyphenylene sulfide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- KCTAWXVAICEBSD-UHFFFAOYSA-N prop-2-enoyloxy prop-2-eneperoxoate Chemical compound C=CC(=O)OOOC(=O)C=C KCTAWXVAICEBSD-UHFFFAOYSA-N 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 229910052701 rubidium Inorganic materials 0.000 description 2
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012306 spectroscopic technique Methods 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 239000003656 tris buffered saline Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 1
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical group C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 1
- GQWJXNWNTGOVSW-UHFFFAOYSA-N 5-(1-aminoethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(NC(N)C)=CC=CC2=C1S(O)(=O)=O GQWJXNWNTGOVSW-UHFFFAOYSA-N 0.000 description 1
- SJQRQOKXQKVJGJ-UHFFFAOYSA-N 5-(2-aminoethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1S(O)(=O)=O SJQRQOKXQKVJGJ-UHFFFAOYSA-N 0.000 description 1
- ZWONWYNZSWOYQC-UHFFFAOYSA-N 5-benzamido-3-[[5-[[4-chloro-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]diazenyl]-4-hydroxynaphthalene-2,7-disulfonic acid Chemical compound OC1=C(N=NC2=CC(NC3=NC(NC4=CC=C(C=C4)S(O)(=O)=O)=NC(Cl)=N3)=CC=C2S(O)(=O)=O)C(=CC2=C1C(NC(=O)C1=CC=CC=C1)=CC(=C2)S(O)(=O)=O)S(O)(=O)=O ZWONWYNZSWOYQC-UHFFFAOYSA-N 0.000 description 1
- NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241001050985 Disco Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920008285 Poly(ether ketone) PEK Polymers 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- 239000008051 TBE buffer Substances 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical class C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008876 conformational transition Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000005289 controlled pore glass Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002518 isoindoles Chemical class 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical class [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 125000005543 phthalimide group Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
- 229920001643 poly(ether ketone) Polymers 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- ILXAOQAXSHVHTM-UHFFFAOYSA-M sodium;2-amino-2-(hydroxymethyl)propane-1,3-diol;chloride Chemical compound [Na+].[Cl-].OCC(N)(CO)CO ILXAOQAXSHVHTM-UHFFFAOYSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000001018 xanthene dye Substances 0.000 description 1
- 150000003732 xanthenes Chemical class 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G08—SIGNALLING
- G08B—SIGNALLING OR CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS
- G08B15/00—Identifying, scaring or incapacitating burglars, thieves or intruders, e.g. by explosives
- G08B15/02—Identifying, scaring or incapacitating burglars, thieves or intruders, e.g. by explosives with smoke, gas, or coloured or odorous powder or liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/60—Deposition of organic layers from vapour phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/30—Characterised by physical treatment
- C12Q2523/308—Adsorption or desorption
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/30—Characterised by physical treatment
- C12Q2523/31—Electrostatic interactions, e.g. use of cationic polymers in hybridisation reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/185—Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
Definitions
- the present invention relates to a security system and methods of marking an inventory item and/or a person in the vicinity of the inventory item. More particularly, the present invention relates to incorporating a carrier nucleic acid that includes a DNA taggant having a unique identifiable sequence into a smoke fluid, and discharging the smoke fluid including the carrier nucleic and the DNA taggant onto various surfaces for inventory identification, authentication or tracking, as well as for marking intruders.
- security systems including smoke generators or fog generators have been developed. These systems can in just a few seconds produce a thick cloud of artificial disorienting and impenetrable smoke or fog.
- smoke or fog security systems immediately stop intruders and would be thieves in their tracks by obscuring everything from sight within seconds. This disorienting fog usually results in redirecting the intruders' efforts from targeting valuables for theft to finding an exit from the building.
- the security smoke or fog systems can also be used in conjunction with audio and lighting to provide an even stronger deterrent. These systems are designed to provide protection in that critical time between activation of the system and the arrival of a response team.
- Security smoke or fog generators can be easily integrated into existing alarm systems, such as access and control systems and closed circuit television (CCTV) security systems.
- CCTV closed circuit television
- these security smoke or fog systems may prevent theft and/or minimize the amount of such theft, the available security smoke or fog systems do not provide a method to later identify the intruders/thieves and/or uniquely identify any recovered inventory item that were missing from the premises.
- a method of marking an inventory item includes providing an activatable smoke generator and a reservoir for holding a smoke fluid and adapted to provide a flow of smoke fluid to the generator.
- the reservoir contains a smoke fluid incorporating a carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence.
- the method further includes activating the smoke generator to produce the marker smoke including the carrier nucleic acid that includes the DNA taggant so as to cause the marker smoke to flow over the inventory item and thereby to detectably mark the inventory item with the carrier nucleic acid and DNA taggant.
- the present invention also provides a method of marking a person in the vicinity of an activated smoke generator, the method includes providing an activatable smoke generator and a reservoir for holding a marker smoke fluid and adapted to provide the flow of marker smoke fluid to the generator; the reservoir containing a marker smoke fluid incorporating a carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence, and activating the smoke generator to produce the marker smoke including the carrier nucleic acid and the DNA taggant so as to cause the marker smoke to flow over a person in the vicinity of the smoke generator and thereby to detectably mark the exposed body surface and/or one or more items of clothing of the person with the carrier nucleic acid and the DNA taggant.
- a security system in still another exemplary embodiment, includes an activatable smoke generator, a reservoir for holding a smoke fluid and adapted to provide a flow of smoke fluid to the generator, wherein the smoke fluid includes a carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence.
- the present invention provides methods of immobilizing a deoxyribonucleic acid to a substrate or of binding a deoxyribonucleic acid to a substrate.
- the method includes exposing the deoxyribonucleic acid to alkaline pH, and contacting the alkaline exposed deoxyribonucleic acid to the substrate.
- One embodiment of the present invention provides a method of binding of a deoxyribonucleic acid to a substrate, wherein the method includes exposing the deoxyribonucleic acid to alkaline conditions wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkaline solution having a high pH (such as for instance a pH of about 9.0 to about 14.0), and contacting the alkaline-exposed deoxyribonucleic acid to the substrate.
- the alkaline solution is a solution of a hydroxide of an alkali metal.
- the alkaline solution is a solution of a high pH buffer.
- the high pH buffer is selected from the group consisting of CABS (4-[cyclohexylamino]-1-butanesulphonic acid), CAPS (N-cyclohexyl-3-amino-propanesulfonic acid), AMP (2-amino-2-methyl-1-propanol), CAPSO (N-cyclohexyl-2-hydroxyl-3-aminopropanesulfonic acid), CHES (2-(N cyclohexylamino) ethanesulphonic acid), AMPSO (3-[(1,1-dimethyl-2-hydroxyethyl) amino]-2-hydroxypropanesulfonic acid) and a mixture of any two or more of the foregoing.
- FIG. 1 shows data representative of DNA amplification and detection from cotton and wool textile fabrics after exposure to a marker smoke that contains a carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence.
- Panel A is a trace from a capillary electrophoresis separation of PCR amplification products from a sample of cotton fabric exposed to marker smoke containing the DNA taggant having a uniquely identifiable sequence.
- Panel B is a similar trace from a different PCR amplification from a sample of wool fabric exposed to marker smoke containing the DNA taggant having a uniquely identifiable sequence.
- FIG. 2 shows DNA authentication from an operator immediately after exposure to marker smoke that includes a carrier nucleic acid and a DNA taggant having a uniquely identifiable sequence.
- the panels A, B, C and D show traces of PCR amplification products from samples taken from swabs of the operator's nostril, skin, jacket and shoes respectively after separation by capillary electrophoresis.
- FIG. 3 shows DNA authentication from an operator after 48 hours post exposure to marker smoke that includes a carrier nucleic acid and a DNA taggant having a uniquely identifiable sequence.
- the four panels A, B, C and D show traces from capillary electrophoresis separation of PCR amplification products from samples taken from swabs of the operator's nostril, skin, jacket and shoes, respectively.
- FIG. 4 shows DNA authentication from hands and shoes of an operator up to one week post exposure to marker smoke that includes a carrier nucleic acid and a DNA taggant having a uniquely identifiable sequence.
- Panel A shows a trace from a capillary electrophoresis separation of PCR amplification products from a sample obtained by swabbing the operator's hand six days after exposure.
- Panel B shows a trace from a capillary electrophoresis separation of PCR amplification products from a sample obtained by swabbing the operator's shoes one week after exposure to marker smoke that includes a carrier nucleic acid with a DNA taggant having a uniquely identifiable sequence.
- FIG. 5 shows authentication of a wool jacket thirty days after exposure to marker smoke that includes a carrier nucleic acid and a DNA taggant having a uniquely identifiable sequence, the jacket having been subjected to dry cleaning after exposure to marker smoke that includes a carrier nucleic acid with a DNA taggant having a uniquely identifiable sequence.
- DNA taggant means a nucleic acid tag which comprises deoxy nucleotides.
- a DNA taggant may be double stranded or single stranded, cDNA, STR (short tandem repeats) and the like.
- the DNA taggant may also include modification to one or more nucleotides which aid in the identification or detection of the DNA taggant.
- DNA taggant as used herein means a DNA maker comprising a uniquely identifiable sequence that can be utilized to identify or authenticate a particular item or product, or even to identify or authenticate the exposed body surface or hair of a person exposed to marker smoke or fog containing the DNA taggant.
- identity means a nucleotide sequence which can be detected by hybridization and/or PCR technology by a primer or probe designed for specific interaction with the target nucleotide sequence to be identified.
- the interaction of the target nucleotide sequence with the specific probe or primer can be detected by optical and/or visual means to determine the presence of the target nucleotide sequence.
- inventory item as used herein is defined as any inanimate object within the range of the marker smoke or fog produced from a smoke generator.
- linker means a compound or a composition which covalently links a biomolecule to the surface of a coated emitting reporter. For example, but not limited to a silylated coated upconverting phosphor particle linked to a DNA molecule.
- oligomer refers to any chemical entity that can be covalently linked to one or more other such entities to form an oligomer or a polymer.
- examples of “monomers” include nucleotides, amino acids, saccharides and the like.
- nucleic acid means a polymer composed of nucleotides which can be deoxyribonucleotides or ribonucleotides. These compounds can be natural or synthetically produced deoxyribonucleotides or ribonucleotides.
- the synthetically produced nucleic acid can be of a naturally occurring sequence, or a non-natural unique sequence.
- nucleotide means a monomeric unit comprising a sugar phosphate, usually ribose-5′-phosphate or 2′-deoxyribose-5′-phosphate covalently bonded to a nitrogen-containing base, usually, adenine (A), guanine (G), cytosine (C), or thymine (T) in the case of a deoxyribonucleotide, and usually, adenine (A), guanine (G), cytosine (C), or uracil (U) in the case of ribonucleotides.
- adenine (A), guanine (G), cytosine (C), or uracil (U) in the case of ribonucleotides.
- Nucleic acids can hybridize with complementary nucleic acids in a sequence specific manner. That is they can participate in hybridization reactions in which the complementary base pairs A:T (adenine:thymine) and G:C (guanine:cytosine) form intermolecular (or intra-molecular) hydrogen bonds and cooperative stacking interactions between the planar neighboring bases in each strand through Pi electrons, together known as Watson-Crick base pairing interactions.
- the bases of the nucleic acid strands can also hybridize to form non-Watson-Crick base pairs by so-called “wobble” interactions in which G (guanine) pairs with U (uracil), or alternatively, I (inosine) pairs with C (cytosine), U (uracil) or A (adenine).
- oligomer refers to a chemical entity that contains a plurality of monomers.
- oligomer and “polymer” are used interchangeably.
- examples of oligomers and polymers include polydeoxyribonucleotides (DNA), polyribonucleotides (RNA), other polynucleotides which are C-glycosides of a purine or pyrimidine base, polypeptides (proteins), polysaccharides (starches, or polysugars), and other chemical entities that contain repeating units of like chemical structure.
- polynucleotide or “nucleotide” refer to single or double stranded polymer composed of covalently nucleotide monomers forming a chain of generally greater than twenty to fifty nucleotides in length.
- phosphor particle means a particle or composition comprising at least one type of upconverting phosphor material.
- primer means a nucleotide with a specific nucleotide sequence which is sufficiently complimentary to a particular sequence of a target DNA molecule, such that the primer specifically hybridizes to the target DNA molecule.
- probe refers to a binding component which binds preferentially to one or more targets (e.g., antigenic epitopes, polynucleotide sequences, macromolecular receptors) with an affinity sufficient to permit discrimination of labeled probe bound to target from nonspecifically bound labeled probe (i.e., background).
- targets e.g., antigenic epitopes, polynucleotide sequences, macromolecular receptors
- probe polynucleotide means a polynucleotide that specifically hybridizes to a predetermined target polynucleotide.
- PCR refers to a polymerase chain reaction.
- PCR is an amplification technology useful to expand the number of copies of a template nucleic acid sequence via a temperature cycling through melting, re-annealing and polymerization cycles with pairs of short primer oligonucleotides complementary to specific sequences bordering the template nucleic acid sequence in the presence of a DNA polymerase, preferably a thermostable DNA polymerase such as the thermostable Taq polymerase originally isolated from the thermophillic bacterium ( Thermus aquaticus ).
- PCR includes but is not limited to standard PCR methods, where in DNA strands are copied to provide a million or more copies of the original DNA strands (e.g.
- PCR using random primers See for instance PCR with Arbitrary Primers: Approach with Care. W. C. Black IV, Ins. Mol. Biol. 2: 1-6 Dec. 2007); Real-time PCR technology, wherein the amount of PCR products can be monitored at each cycle ( Real time quantitative PCR : C. A. Heid, J. Stevens, K. J. Livak and P. M. Williams, 1996 Genome Research 6: 986-994); Reverse transcription-PCR wherein RNA is first copied in DNA stands and thereafter the DNA strands are amplified by standard PCR reactions (See for example: Quantitative RT - PCR: Pitfalls and Potential : W. F. Freeman, S. J. Walker and K. E. Vrana; BioTechniques 26:112-125, January 1999).
- ribonucleic acid and “RNA” denote a polymer composed of ribonucleotides.
- deoxyribonucleic acid and “DNA” denote a polymer composed of deoxyribonucleotides.
- a “carrier nucleic acid” as used in this application means a bulk nucleic acid that can include large nucleic acid molecules, nucleic acid oligomers or nucleic acid fragments used as carrier for a DNA taggant having a unique identifiable sequence to identify or authenticate a particular product or to mark individuals present during fogging with the carrier nucleic acid.
- the carrier nucleic acid is generally present in a vast excess (w/w) over the amount of DNA taggant, so that isolation or even detection of the DNA taggant is impossible without prior knowledge of at least a portion of the uniquely identifiable sequence of the DNA taggant.
- DNA taggant and the carrier nucleic acid may be likened to the proverbial “needle in a haystack” wherein the DNA taggant is the analog of the needle hidden in the haystack of carrier nucleic acid.
- person may be defined as a homeowner, an employee, a shopper or other invitee, a licensee such as a repair person, or a trespasser or intruder.
- One embodiment of the present invention provides a method of marking an inventory item.
- the method includes providing an activatable smoke or fog generator and a reservoir for holding a marker smoke fluid and adapted to provide a flow of marker smoke fluid to the generator.
- the reservoir contains a marker smoke fluid including a carrier nucleic acid that includes DNA taggant having a uniquely identifiable sequence, and upon activation of the smoke generator, a marker smoke or fog is generated and caused to flow over the inventory item.
- the method further includes activating the smoke generator to produce the marker smoke including the carrier nucleic acid and DNA taggant so as to cause the marker smoke to flow over the inventory item and thereby to detectably mark the inventory item with DNA taggant.
- Exemplary embodiments of the present invention also provide a security system.
- the security system includes a smoke generator, a reservoir for holding a marker smoke fluid and adapted to provide a flow of marker smoke fluid with carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence to the smoke generator.
- a fog machine or smoke machine is used in exemplary embodiments of the present invention to create a fog or smoke to mark the above-mentioned inventory items with the carrier nucleic acid that includes the DNA taggant having a uniquely identifiable sequence.
- the term “fog machine” and “smoke machine” may be used interchangeably throughout to mean the same thing.
- the terms “fog” and “smoke” may be used interchangeably throughout to mean the same thing.
- the fog machine or smoke machine is, for example, a device which emits smoke such as a marker smoke for deterring intruders from remaining on the premises and which contains the carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence for marking an inventory item and/or person present on the premises at the time of the activation of the smoke or fog generator with the carrier nucleic acid that includes the DNA taggant.
- suitable fog machines or smoke machines include water-based fog machines, oil based fog machines and chill fog machines.
- the present exemplary embodiment relates to water-based fog machines.
- oil based fog machines and chill fog machines can also be used.
- a water-based fog machine may include, for example, a fluid reservoir or tank, a pump (e.g. electric pump) to move the smoke fluid including carrier nucleic acid that contains the DNA taggant and a heat exchanger which vaporizes the smoke fluid with the DNA taggant.
- a pump e.g. electric pump
- More complex models may include a variety of other features, including variable speed pumps to control the output of fog, timer modules, or components for remote operation and monitoring the status of the fog machine.
- the water-based fog machine produces a marker smoke including the carrier nucleic acid that includes the DNA taggant having a uniquely identifiable sequence, which is a thermally generated white smoke specifically used as a security measure.
- This marker smoke including carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence may be created, in the water-based fog machine by, for example, vaporizing glycol (e.g., diethylene glycol, dipropylene glycol, propylene glycol, or triethylene glycol) or glycerine mixed with distilled water over a high temperature heat source and heated above its boiling range in the fog machine.
- the fog fluid in the fluid tank is forced through a heat exchanger by a high pressure pump.
- the heat exchanger maintains a high temperature at which the fluid vaporizes in a process commonly known as “flashing”. As the fluid is “flashed” it rapidly expands, and that expansion forces the vapor through the nozzle of the machine.
- the vapor Upon exiting the smoke or fog machine and coming into contact with the cooler air outside the fog machine, the vapor cools very rapidly and condenses, thereby rapidly forming a dense white fog composed of millions of microscopic liquid particles suspended in the air which obscures vision to the extent that even objects a few inches away are not readily visible and thus presents a confrontational barrier or obstacle to any intruders.
- the very dense white appearance of the marker smoke or fog is caused by light refracting through the particles and scattering back. Because the particles produced are so small (varies from manufacturer to manufacturer, but typically range from an average diameter of, for example, about 0.2 microns to about 2.0 microns), the marker smoke or fog settles extremely slowly. In some embodiments, the marker smoke can last for an extended period after the smoke generator is shut down, and yet due to the very fine droplets, the marker smoke does not settle on surfaces to any discernable level and thus does not visibly contaminate exposed items or inventory.
- the marker smoke or fog In contrast to surveillance cameras and alarms systems, the marker smoke or fog immediately stops intruders in their tracks by obscuring from sight within seconds everything that could be stolen or vandalized, and disorienting the intruder or intruders. This leaves the intruder with few options other than to exit the building as quickly as possible.
- the marker smoke or fog can be a non-toxic, glycol-based liquid which dissipates quickly with no residue and does not harm persons or paper or electronics.
- the fog machine or smoke machine is a water-based fog machine or smoke machine including a reservoir for holding the marker smoke fluid including the carrier nucleic acid and a DNA taggant having a uniquely identifiable sequence.
- Security smoke or fog generators useful in the practice of the present invention include for example, SmokeCloak security fog generators (such as SmokeCloak Vali V20, SmokeCloak Vali V 10, SmokeCloak Vali V5, Smoke Cloak IPX range, Smoke Cloak Vali System 1000, SmokeCloak Vali System 2000, Smoke Cloak Vali System 3000, Smoke Cloak Vali System 4000, Smoke Cloak Vali System 4000 x-stream, Smoke Cloak Vali System 8000, SmokeCloak Vehicle Range System 24 from SmokeCloak, Denmark, FoQus, Protect 600, Protect 1100, Protect 220 from Protect A/S, Hasselager, Denmark, T-1500, T-1500X2, P-1500, P-1500X2 from Flash Fog Security, Ontario Canada, Bandit 240DB, 240PB from Bandit N
- the smoke fluid stored in the reservoir of the device which is mixed with the carrier nucleic acid and DNA taggant for security/fog marker smoke is, for example, a water-based fluid including food or medical grade glycols and deionized water.
- water-based smoke fluids include, for example, FL600-V and FL-600, from SmokeCloak, Denmark, XTRA+ from Protect A/S, Hasselager, Denmark, FlashFog from FlashFog Security, Ontario Canada, and HY-3 cartridge pack from Bandit 240DB, 240PB from Bandit N/V, Opglabbeek, Belguim or any other suitable smoke fluid known to those of ordinary skill in the art.
- the fog machine or smoke machine may be an oil-based fog machine or smoke machine.
- the carrier nucleic acid containing a DNA taggant is likewise included in these oil-based smoke fluids for marking purposes.
- oil-based smoke fluids may include, for example, mineral oil (for instance baby oil).
- Gas propelled smoke or fog machines use an inert gas (most commonly carbon dioxide or nitrogen) to propel the mineral oil into a heat exchanger where the smoke fluid is atomized and sent into the air to produce the marker smoke that incorporates the carrier nucleic acid that includes the DNA taggant.
- inert gas most commonly carbon dioxide or nitrogen
- These oil-based smoke fluids which are converted into marker smoke or fog machines are similar in principle to smoke fluid created by glycol based smoke fluid except that the marker smoke of the oil-based marker smoke can withstand much higher temperatures and is much more dense than the marker smoke created by the glycol based marker fluids.
- oil-based smoke or fog is much denser and hangs in the air many times longer than water based fog, as the fog particles don't evaporate as quickly.
- oil-based marker smoke is perfectly safe, non-toxic, intrinsically biodegradable and does not leave a residue.
- Suitable oil-based smoke or fog machines include for example Phantom PS31, Phantom PS 33 from Pea Soup Ltd., United Kingdom, Max 3000 APS Fog Generator, Max 5000 Fog APS Fog Generator, Max 5000 H.O. (High Output) APS Fog Generator from A.C.T. Lighting, Inc. at www.actlighting.com, and SG-OB30—Oil Based Smoke Generator Machine from Froggys Fog, Columbia, Tenn.
- the oil-based smoke fluid may include, for example, MDG Neutral Fog Fluid from A.C.T. Lighting, Inc. at www.actlighting.com, PSSO180-5L: Smoke Oil 180, PSSO180-205L: Smoke Oil 180 from Pea Soup Ltd., United Kingdom, and Formula O Smoke Oil Fluid from www.froggysfog.com.
- the security system may include other types of smoke or fog machines which do not use glycol based smoke fluid or mineral oil-based smoke fluid. Rather, these other embodiments may include chilled fog machines which create a low lying heavy fog that uses dry ice (i.e., solid carbon dioxide), or liquid nitrogen. In these embodiments, the carrier nucleic acid containing the DNA taggant is likewise included in the resulting fog. Unlike other types of smoke or fog machine, which create a smoke or fog that hangs in the air or rises, the fog created by dry ice or liquid is cold, and therefore sinks to the ground or to the lowest available level.
- these other embodiments may include chilled fog machines which create a low lying heavy fog that uses dry ice (i.e., solid carbon dioxide), or liquid nitrogen.
- the carrier nucleic acid containing the DNA taggant is likewise included in the resulting fog.
- the fog created by dry ice or liquid is cold, and therefore sinks to the ground or to the lowest available level.
- Suitable chilled smoke or fog machines for use in the practice of the present invention include, for example, Peasouper Dry Ice Fog Machine Le Maitre Pea Soupe and FreezeFog Pro Heavy Fog Chiller from Pea Soup Ltd., United Kingdom, Chauvet Nimbus Dry Ice Fog Machine, Product #: CVT NIMBUS LIST from Chauvet Lighting, Sunrise, Fla. City Theatrical SS6000 Dry Ice Fogger, Catalog # SFXF-0296 from Production Advantage, Inc, Williston, Vt.
- the security system may further be coupled to a colored light element which is also activated when the smoke or fog generator is activated.
- the colored light element when activated shines on the clear fog to such that the fog reflects the colored light rather than normal/white light to thereby produces a colored smoke or fog.
- the DNA taggant may be provided in a canister or a smoke grenade, similar to that used by the military to create a smoke screen.
- canisters are constructed of a metal cylinder with holes on the top and bottom that release smoke when ignited by the pulling of a pin or some other activation mechanism.
- Many smoke canisters contain dye that produces colored smoke when ignited.
- the smoke or fog can be produced a variety of colors, such as for example, red, purple, orange, yellow, blue, green, gray, white and black.
- the smoke generators can be installed, for example, above ceilings or high on walls.
- the smoke is forced vertically downwards and then rises forming a thickening barrier, which protects the smoke or fog generating device, itself, as well as the premises and contents.
- the smoke or fog machine may also be placed in any other suitable locations desired than those mentioned above.
- the smoke or fog machine may be concealed within walls of the premises or placed within air ducts.
- the smoke or fog machine may be placed, for example, on the floor of the premises.
- the security smoke or fog machines may be triggered by activation of an alarm system.
- the security smoke or fog generators of the present exemplary embodiment may be part of an existing intruder alarm system.
- a heater element in the security fog generator converts liquid glycerol into an extremely dense artificial fog that is immediately spread throughout the area.
- the security smoke or fog system may be part of an independent system with dedicated detectors and an alarm panel which triggers the fog security generator device. This prevents the smoke or fog security system from activating if the intruder alarm is not confirmed, such as for instance a false alarm due to air movements e.g. movement caused by convection from an air conditioner detected by a motion sensor.
- These detectors are referred to as “hold-offs” in that they prevent the system from activating until movement is confirmed.
- the security system may further include additional deterrent accessories.
- the security system may further include a bright, high intensity, flashing strobe light which amplifies the blinding effect of the marker smoke or fog. The rapidly flashing light prevents any attempts to see through the smoke or fog, and draws attention to the scene.
- the security system may further include, a sound device, such as, for example, a siren which emits an distracting, but harmless, noise that attracts attention and in combination with the marker smoke forces the intruder to flee immediately.
- the security smoke or fog generator of the present exemplary embodiment may work immediately to protect a person's premises by preventing one or more intruders from taking and/or vandalizing property. For example, within seconds the intruder may be completely disoriented by the dense fog and immediately needs to leave the premises. Contrast this with the response time by the police and key holder (e.g. owner of the premises) which even in the best circumstances will take at least a few minutes. However, by the time they arrive to investigate the effects of the alarm activation, the intruders may already be gone and with property stolen from the premises.
- the security smoke or fog generators of the present exemplary embodiment rapidly inhibit the intruders from remaining on the premises and thereby minimize and/or prevent theft.
- the fog discharged from the security fog generator of the present exemplary embodiment is a marker smoke or fog that includes a carrier nucleic acid containing a DNA taggant having a uniquely identifiable sequence
- exposed areas of the intruder such as skin, hair and clothing as well as inventory items taken from the premises are marked with the carrier nucleic acid and DNA taggant and can be later identified by using authentication techniques to determine whether the person of interest and/or item where at the location at the time of the crime in question, as will be discussed in detail below.
- a person in the vicinity of the inventory item is exposed to the marker smoke or fog, the person having an exposed item of clothing and/or an exposed body surface, and thereby to detectably marking the exposed item of clothing and/or the exposed body surface of the person in the vicinity of the inventory item with marker smoke and carrier nucleic acid that includes the DNA taggant having a uniquely identifiable sequence.
- the exposed areas of the human body which may be marked with the marker smoke generated by the security fog generator include, for example, the hair, skin, and nostrils.
- the exposed items of clothing of a person which may be marked with the marker smoke generated by the security smoke or fog generator may be any item of clothing, such as, for example, hats, gloves, jackets, coats, shirts, sweaters, pants, jeans, sweat pants, shorts, t-shirts, tank tops, suits, ties, dresses, skirts, swim wear, socks, shoes, sneakers, and boots.
- the detectably marked exposed item of clothing of a person may be any fabric or material, such as, for example, wool, cotton, linen, satin, rayon, viscose, polyester, nylon, acrylic, olefin, polyurethane, polylactide, plastic, leather, or an artificial fur or animal fur.
- the security fog generator may protecting retailers of high value items, such as jewelers and banks.
- the security smoke or fog generator may also provide protection for ATM's and other areas where there are large amounts of cash.
- the security smoke or fog generators may be used to protect businesses such as foreign exchange offices. These smoke or fog generators can also be used in private homes.
- security/marker smoke or fog generators are not restricted to applications in small premises, but rather can also be deployed to protect offices, warehouses, casinos, gas service stations. These may be large and isolated premises, where it can be difficult to provide a rapid response to intruders.
- the security smoke or fog generators of the present exemplary embodiment can be accurately deployed and triggered to protect valuable inventory items, while still allowing intruders to leave the premises.
- the security/marker smoke or fog generators can also be installed in a vehicle for protection of the vehicle and the items contained therein.
- this security/marker smoke or fog generator installed in a vehicle may be targeted to companies which transport desirable or high-value goods such as drugs, cigarettes, electronics, alcohol and cash.
- the dense smoke created by the security.marker smoke or fog generator is completely harmless.
- the smoke or fog may be created using, for example, the same principles as are used for smoke or fog machines in theatres, night clubs and discos.
- the dense smoke or fog created by the security fog generator is suitable for virtually every environment as the fog is non-toxic and leaves no residue. This means that there is no damage to clothing, equipment, furnishings, machines, and it is safe to use in areas routinely used by staff, customers or even animals.
- the dense smoke emitted from the security smoke or fog generator includes a carrier nucleic acid that contains a DNA taggant having a uniquely identifiable sequence
- the intruder's clothing, skin, hair, face, nostrils, hands, and/or inventory items taken by the intruder can be marked with the carrier nucleic acid and DNA taggant by the emitted smoke or fog such that the intruder and/or stolen object containing the carrier nucleic acid and DNA taggant can later be identified and authenticated.
- the security/marker smoke or fog generators of the present exemplary embodiment not only provide a deterrent against intruders and thieves from remaining on the premises, but also provide a way to later identify an intruder for criminal prosecution and/or identify an inventory item removed from the protected premises.
- alkali treatment of isolated DNA also activates the DNA for covalent binding. Without wishing to be bound by theory, it is believed that alkaline conditions lead to ionization of the free hydroxyls at the 3′ ends of the DNA strands.
- the negatively charged —O— group produced at the 3′ end of the DNA is a strong nucleophile, reactive with positively charged groups to form stable covalent bonds, stably binding the DNA.
- the invention provides methods of binding of a deoxyribonucleic acid to a substrate:
- the method includes exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid to the substrate.
- the DNA bound to the substrate is available for binding by hybridization probes, PCR amplification and DNA sequencing methods.
- the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkaline solution having a high pH, for instance the pH of the alkaline solution can be a pH of about 9.0 or higher; a pH of about 10.0 or higher; a pH of about 11.0 or higher, or even a pH of about 12.0 or higher, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate.
- the alkaline solution is a solution of a hydroxide of an alkali metal.
- Another embodiment of the present invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkaline solution, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline solution is a solution of a hydroxide of an alkali metal and the alkali metal is selected from the group consisting of lithium (Li), sodium (Na), rubidium (Rb), and cesium (Cs).
- Another embodiment of the present invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkaline solution, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline solution is a solution of an alkali metal hydroxide, wherein the alkali metal hydroxide is selected from the group consisting of lithium hydroxide (LiOH), sodium hydroxide (NaOH) and cesium hydroxide (CsOH). In one embodiment, the alkali metal hydroxide is sodium hydroxide (NaOH).
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide, wherein the alkali metal hydroxide solution having a concentration of from about 1 mM to about 1.0 M.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide, the alkali metal hydroxide solution having a concentration of from about 10 mM to about 0.9 M.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide, the alkali metal hydroxide solution having a concentration of from about 0.1 M to about 0.8 M.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide, the alkali metal hydroxide solution having a concentration of from about 0.4 M to about 0.8 M.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide, the alkali metal hydroxide solution having a concentration of about 0.6 M.
- Another embodiment of the present invention provides a method of binding of a deoxyribonucleic acid to a substrate, wherein the method includes exposing the deoxyribonucleic acid to alkaline conditions and contacting the alkaline exposed deoxyribonucleic acid to the substrate, wherein the deoxyribonucleic acid is mixed with an alkaline solution having a pH from about 9.0 to about 14.0 and incubated at a temperature of from about 0° C. to about 65° C. to produce the alkaline conditions.
- Another embodiment of the present invention provides a method of binding of a deoxyribonucleic acid to a substrate, wherein the method includes exposing the deoxyribonucleic acid to alkaline conditions and contacting the alkaline exposed deoxyribonucleic acid to the substrate, wherein the deoxyribonucleic acid is mixed with an alkaline solution having a pH from about 9.0 to about 14.0 and incubated at a temperature of from about 5° C. to about 55° C. to produce the alkaline conditions.
- Another embodiment of the present invention provides a method of increasing binding of a deoxyribonucleic acid to a substrate, wherein the method includes exposing the deoxyribonucleic acid to alkaline conditions and contacting the alkaline exposed deoxyribonucleic acid to the substrate, wherein the deoxyribonucleic acid is mixed with an alkaline solution having a pH from about 9 to about 14 and incubated at a temperature of from about 10° C. to about 45° C. to produce the alkaline conditions.
- Another embodiment of the present invention provides a method of increasing binding of a deoxyribonucleic acid to a substrate, wherein the method includes exposing the deoxyribonucleic acid to alkaline conditions and contacting the alkaline exposed deoxyribonucleic acid to the substrate, wherein the deoxyribonucleic acid is mixed with an alkaline solution having a pH from about 9 to about 14 and incubated at a temperature of from about 15° C. to about 35 t to produce the alkaline conditions.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide and incubating the mixture at a temperature of from about 0° C. to about 65° C.
- Another embodiment of the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with a solution of an alkali metal hydroxide and incubating the mixture at a temperature of from about 15° C. to about 22° C.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkali metal hydroxide solution having concentration of from about 0.1 M to about 1.0 M and incubating the mixture for a period of from about 1 minute to about 6 hours at a temperature of from about 10° C. to about 45° C.
- the invention provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkali metal hydroxide solution having concentration of from about 0.1 M to about 1.0 M and incubating the mixture for a period of from about 1 minute to about 6 hours at a temperature of from about 15° C. to about 25 t to produce the alkaline conditions.
- Another embodiment provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkali metal hydroxide solution having concentration of about 0.6 M and incubating the mixture for a period of from about 1 minute to about 6 hours at a temperature of from about 15° C. to about 35° C.
- Another embodiment provides a method of binding a deoxyribonucleic acid to a substrate, the method including exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkali metal hydroxide solution having concentration of about 0.6 M and incubating the mixture for a period of from about 10 minutes to about 2 hours at a temperature of from about 18° C. to about 22 t to produce the alkaline conditions.
- the present invention provides a method of binding a deoxyribonucleic acid to a substrate, the method includes exposing the deoxyribonucleic acid to alkaline conditions, wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkaline solution having a high pH, incubating the mixture and then neutralizing the alkaline solution and contacting the neutralized solution containing the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate.
- the alkaline solution is a solution of a hydroxide of an alkali metal selected from the group consisting of lithium (Li), sodium (Na), rubidium (Rb), and cesium (Cs).
- the present invention provides a method of binding a deoxyribonucleic acid to a substrate, the method includes exposing the deoxyribonucleic acid to alkaline conditions, and contacting the deoxyribonucleic acid that has been exposed to the alkaline conditions with the substrate; wherein the alkaline conditions are produced by mixing the deoxyribonucleic acid with an alkali metal hydroxide solution, and adding a molar excess of a polyionic polymer.
- the polyionic polymer can be any suitable polyionic polymer.
- the polyanionic polymer is a polyamino acid.
- the polyamino acid can be a homopolymer of a natural amino acid such as L-lysine, or a homopolymer of a non-naturally occurring amino acid, such as for instance D-lysine.
- the polyamino acid homopolymer is selected from the group consisting of polyputrescine, polycadaverine, polyspermidine, and polylysine.
- deoxyribonucleic acid can be mixed with a solution of any suitable high pH buffer to produce the alkaline conditions.
- the high pH buffer can be any suitable high pH buffer with a pKa in a range of from about 9.0 to about 11.0 or higher.
- the pH of the high pH buffer can be, for example, a pH of about 9.0 or higher; a pH of about 10.0 or higher; or a pH of about 11.0 or higher.
- deoxyribonucleic acid can be mixed with a suitable high pH buffer such as CABS (4-[cyclohexylamino]-1-butanesulphonic acid) with a useful pH range of about 10.0-11.4 (at 25° C.) and a pKa of about 10.70 (at 25° C.) Product No. C5580 Sigma Aldrich, St.
- a suitable high pH buffer such as CABS (4-[cyclohexylamino]-1-butanesulphonic acid) with a useful pH range of about 10.0-11.4 (at 25° C.) and a pKa of about 10.70 (at 25° C.) Product No. C5580 Sigma Aldrich, St.
- AMPSO (3-[(1,1-dimethyl-2-hydroxyethyl)amino]-2-hydroxypropanesulfonic acid) with a useful pH range of about 8.3-9.7 (at 25° C.), a pKa of about 9.00 (at 25° C.), a pKa of about 9.10 (at 37° C.) Sigma Aldrich Product Nos. A6659 and A7585, to produce the alkaline conditions.
- the deoxyribonucleic acid that has been exposed to the alkaline conditions is added as a component of a liquid composition.
- the liquid composition any be any suitable liquid composition, such as for instance, a printing ink.
- the ink may be a heat-curing epoxy-acrylate ink, such as Product No. 4408R or the 970 series Touch Dry® pellet each from Markem®, Keene, N.H.
- the Artistri® P5000+ Series-Pigment Ink from Dupont®, or an Epoxy Acrylate Ink, such as Product No. 00-988, from Rahn USA Corp. can be used.
- the taggants of the present invention include, for example, nucleic acid taggants.
- Nucleic acid is a general term for deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), and can be synthetic, or derived from an animal, a plant, a bacterium, a virus, a fungus, or a synthetic vector or a fragment of any of the above-listed nucleic acids, etc.
- a synthetic nucleic acid can have a sequence of a naturally occurring nucleic acid of an animal, plant, bacterium, fungus, virus or any other organism or synthetic vector.
- a synthetic nucleic acid can have a unique sequence not found in nature.
- nucleic acid sequence encoding the element of data or indicia encrypted or encoded in the taggant of the invention is a unique, non-natural sequence and thereby is adapted for use in authentication of an object of interest.
- the taggant useful in combination with the bound DNA that has been activated by alkaline treatment according to the present invention can be any suitable detectable or traceable taggant, for example, a chemical marker or a biological marker.
- the taggant is selected from a UV fluorophore, a ceramic IR marker, other DNA, an amino acid, a peptide, a protein, a lipid, a sugar, a polysaccharide, a pheromone, a scent, a trace element, a rare earth element, or a combination of any two or more thereof.
- the taggant includes a nucleic acid.
- the taggant consists essentially of DNA and no other significant component useful for identification or authentication.
- taggants such as, for example, ultraviolet (UV) taggants, Up Converting Phosphor (UCP) infrared (IR) taggants, UV marker taggants, UV fluorophore taggants, ceramic IR marker taggants, protein taggants, and/or trace element taggants can be used in combination with deoxyribonucleic acid taggants activated by alkaline treatment according to the methods of the present invention.
- the taggants used may include, for example, a combination of DNA taggants, and an IR upconverting phosphor (UCP) taggant.
- the taggants used may include, for example, a combination of DNA taggants, an IR upconverting phosphor (UCP) taggant and a UV taggant.
- the IR (UCP) taggant can be, for example, a green, a blue or a red (UCP) IR taggant, such as for instance the Green IR Marker, Product No. BPP-1069; the Blue UCP, Product No. BPP-1070; or the Red UCP, Product No. BPP-1071 from Boston Applied Technologies Inc., Woburn, Mass.
- the solution in which the soluble taggants are dissolved according to the methods of the present invention can include, for example, water, TE buffer (10 mM Tris-HCl, 1 mM EDTA), Tris-glycine buffer, Tris-NaCl buffer, TBE buffer (Tris-borate-EDTA), TAE buffer (Tris-acetate-EDTA) and TBS buffer (Tris-buffered saline), HEPES buffer (N-(2-Hydroxyethyl)piperazine-N′-ethanesulfonic acid), MOPS buffer (3-(N-Morpholino)propanesulfonic acid), PIPES buffer (Piperazine-N,N′-bis(2-ethanesulfonic acid), MES buffer (2-(N-Morpholino)ethanesulfonic acid), PBS (Phosphate Buffered Saline), PBP buffer (sodium phosphate+EDTA), TEN buffer (Tris
- the objects of interest marked with the deoxyribonucleic acid and optional additional taggants include, for example, ceramic surfaces, plastic films, vinyl sheets, antiques, items of jewelry, identification cards, credit cards, magnetic strip cards, paintings, artwork, souvenirs, sports collectibles and other collectibles. The authenticity of these objects can then be verified by identifying the taggants bound or covalently bonded thereon through, for example, methods described in further detail below.
- the surface to which the deoxyribonucleic acid that has been exposed to alkaline conditions is bound can be the surface of an object or item formed of a polymer, such as a polymer selected from the group consisting of polycarbonate (PC), polymethyl methacrylate (PMMA), polyurethane (PU), polystyrene (PS), nylon or polypropylene (PP) all of which are readily commercially available.
- a polymer selected from the group consisting of polycarbonate (PC), polymethyl methacrylate (PMMA), polyurethane (PU), polystyrene (PS), nylon or polypropylene (PP) all of which are readily commercially available.
- the method of the present invention further includes binding an object with the deoxyribonucleic acid that has been exposed to alkaline conditions according to the methods of the present invention, the deoxyribonucleic acid such that the activated deoxyribonucleic acid is chemically bonded to the object, thereby providing the object with authentication, tracking and anti-counterfeiting functions.
- the deoxyribonucleic acid that has been exposed to alkaline conditions that has been applied onto an object provides a traceable deoxyribonucleic acid taggant.
- the traceable deoxyribonucleic acid taggant can be applied over all or part of the object to be identified, validated, authenticated, or if the object is an item of commerce, the item can be tracked at any point through the stream of commerce.
- the traceable deoxyribonucleic acid is an alkaline pH activated DNA bound to the object.
- the alkaline pH activated DNA is bound to an object including a material selected from the group consisting of cotton, wool, nylon, plastic, metal, glass, wood, printing ink, and a pharmaceutical powder.
- the alkaline pH activated DNA is bound to a plastic material selected from the group consisting of a polycarbonate (PC), a polymethyl methacrylate (PMMA), a polyurethane (PU), a polystyrene (PS), a polyamide, a polypropylene (PP), a polyvinyl chloride (PVC), polysulphone, polyvinilacetate (PVA), polyester (PES), a polyethylene terephthalate (PET), a polyethylene (PE), a benzocyclobutene (BCB), a high-density polyethylene (HDPE), a polyvinylidene chloride (PVDC), a low-density polyethylene (LDPE), a high impact polystyrene (HIPS), an acrylonitrile butadiene styrene (ABS), a phenol formaldehyde resin (PF), a melamine formaldehyde (MF), a polyetheretherketone (PEE), a
- the object marked with the traceable deoxyribonucleic acid includes a pharmaceutical composition comprising a pharmaceutical tablet, a pharmaceutical capsule, or a pharmaceutical powder.
- Another exemplary embodiment of the present invention provides a method for authenticating an object which includes providing an object to which a taggant is bound or covalently bonded, sampling the object for identification, tracking, or verifying the authenticity of the object by identifying the unique traceable deoxyribonucleic acid (DNA) taggant.
- the unique taggant is a DNA taggant having a unique DNA sequence and the unique DNA sequence is stored in a database that matches the unique DNA sequence to the data elements corresponding to the object which is bound to or covalently bonded to the unique taggant.
- the database can in turn be located on a computer that can be accessed in order to locate, track, authenticate and verify the identity of the tagged object from which the taggant was detected.
- DNA taggants useful in the examples described below include any suitable DNA taggant, such as for instance, in one embodiment, the DNA taggant is a double stranded DNA oligomer having a length of between about 40 base pairs and about 1000 base pairs. In other embodiments the DNA taggant is a double stranded DNA oligomer with a length of between about 80 and 500 base pairs. In another embodiment the DNA taggant is a double stranded DNA oligomer having a length of between about 100 and about 250 base pairs. Alternatively, the DNA taggant can be single-stranded DNA or any suitable length, such as between about 40 bases and about 1000 bases; between about 80 and 500 bases; or between about 100 and about 250 bases. The DNA taggant can be natural DNA, whether isolated from natural sources or synthetic; or the DNA taggant can be a synthetically produced non-natural sequence. All or a portion of the DNA may comprise an identifiable sequence.
- the DNA taggant is identifiable by any suitable detection and/or identification method such as for example, hybridization with a taggant-sequence specific nucleic acid probe, an in situ hybridization method (including fluorescence in situ hybridization: FISH), amplification using a polymerase chain reaction (PCR), such as quantitative/real time PCR and detection of the amplified sequences (amplicons) by any of the variety of standard well known methods.
- a suitable detection and/or identification method such as for example, hybridization with a taggant-sequence specific nucleic acid probe, an in situ hybridization method (including fluorescence in situ hybridization: FISH), amplification using a polymerase chain reaction (PCR), such as quantitative/real time PCR and detection of the amplified sequences (amplicons) by any of the variety of standard well known methods.
- FISH fluorescence in situ hybridization
- PCR polymerase chain reaction
- the hybridization can be carried out with DNA probes, each having a specific nucleotide sequence capable of hybridizing with its complementary sequence.
- Different probes may be included, one to each cell or well of an array or matrix so that only the probe having the complement to the DNA taggant will hybridize and generate a detection signal at the unique location of the complementary probe.
- the complementary probe is present in several cells of wells arranged in a particular pattern, then hybridization with the complementary DNA taggant sequence will be detected in the precise pattern of the specific probes in the array or matrix.
- the nucleic acid taggants e.g., DNA taggants recovered from the object are amplified by polymerase chain reaction (PCR) and resolved by gel electrophoresis. Since the sequence of the nucleic acid taggants of the present invention are unique and specific to the tagged object, the original nucleic acid will be amplified only by use of primers having specific sequences complementary to a portion of the unique taggant sequence. Through this procedure, if the examined object carries the original nucleic acid, the PCR procedure will amplify extracted nucleic acid to produce amplicons of a predetermined size and a sequence identical to a portion of the original nucleic acid sequence of the taggant.
- PCR polymerase chain reaction
- the sample recovered from the examined object does not include the unique nucleic acid corresponding to the authentic object, there will likely be no amplified nucleic acid product, or if the primers do amplify the recovered nucleic acid to produce one or more random amplicons, these one or more amplicons cannot have the unique taggant nucleic acid sequence from the authentic object.
- the random amplicons derived from counterfeit articles are also of random lengths and the likelihood of producing amplicons of the exact lengths specified by the taggant-specific primers is vanishingly small. Therefore, by comparing the sizes of PCR products, the authenticity of labeled objects can be verified, non-authentic objects can be screened and rejected and anti-counterfeit screening purpose is then achieved.
- the number of amplicons amplified and the lengths of the amplicons can be determined after any molecular weight or physical dimension-based separation, such as for instance and without limitation, gel electrophoresis in any suitable matrix medium for example in agarose gels, polyacrylamide gels or mixed agarose-polyacrylamide gels and the electrophoretic separation can be in a slab gel or by capillary electrophoresis.
- the deoxyribonucleic acid that has been exposed to alkaline conditions that has been bound to the item or surface of interest can be subjected to PCR, the PCR amplicons can be recovered and sequenced according to well known routine nucleic acid sequencing techniques.
- the carrier nucleic acid (NA) that includes the DNA taggant having a uniquely identifiable sequence that is incorporated into the smoke fluid of the smoke or fog generator maybe natural DNA, synthetic DNA, cDNA, or other DNA material, or any other nucleic acid fragment comprising DNA or DNA derivatives.
- the carrier nucleic acid may include nucleic acid fragments that are single stranded or double stranded and may vary in length.
- the DNA taggant having a uniquely identifiable sequence can be any DNA having a uniquely identifiable sequence.
- the DNA having a uniquely identifiable sequence can be a totally synthetic DNA, a semi-synthetic DNA wherein a natural DNA fragment or fragments are rearranged and religated to produce the uniquely identifiable sequence, or wherein the natural DNA fragment or fragments are extended or ligated with one or more bases, one or more synthetic oligonucleotides or one or more polynucleotides to produce a DNA taggant having a uniquely identifiable sequence. All such uniquely identifiable sequences are non-natural sequences.
- the DNA taggant can include more than one uniquely identifiable sequence each of which can be separately identified detecting a specific amplicon product of a polymerase chain reaction (PCR) using a primer pair specific for the particular unique sequence.
- the identification can be by any suitable method, such as for instance by sequence determination, by specific hybridization using one or more sequence specific probes or by determination of the length of the PCR amplicon in base pairs after gel electrophoresis or capillary electrophoresis.
- the identification can be by PCR and determination of the length of each of the PCR amplicons in base pairs, wherein each uniquely identifiable sequence and complementary primer pair are chosen to produce an amplicon of a different specific base pair length. The amplicons can then be resolved and identified on the basis of the lengths of each of the amplicons produced from the uniquely identifiable sequences of the DNA taggant.
- the carrier nucleic acid may be synthetically produced using a nucleic acid synthesizer or by isolating nucleic acid material from yeast, human cell lines, bacteria, animals, plants and the like.
- the nucleic acid material may be treated with restriction enzymes and then purified and randomly relegated to produce suitable maker nucleic acid having non-natural sequences.
- the length of the nucleic acid marker/tag usually ranges between about 100 to about 10 kilo bases, more usually about 500 bases to about 6 kb, and preferably about 1 kb to about 3 kb in length.
- the form of the DNA may be linear or circular with sizes ranges from a few bases (5 bases) to genomic DNA (1 million to 30 billion base pairs).
- the uniquely identifiable sequence of the DNA taggant is a sequence of from about 25 bases to about 10,000 bases long. In another exemplary embodiment, the uniquely identifiable sequence of the DNA taggant is a sequence of from about 50 bases to about 5,000 bases long. In another exemplary embodiment, the uniquely identifiable sequence of the DNA taggant is a sequence of from about 75 bases to about 500 bases long. In another exemplary embodiment, the uniquely identifiable sequence of the DNA taggant represents less than one part per ten thousand of the carrier nucleic acid. In another exemplary embodiment, the uniquely identifiable sequence of the DNA taggant represents less than one part per hundred thousand of the carrier nucleic acid. In another exemplary embodiment, the uniquely identifiable sequence of the DNA taggant represents less than one part per million of the carrier nucleic acid.
- the carrier nucleic acid is included in the smoke fluid of the security/marker smoke or fog generator to mark an inventory item and/or a person in the vicinity of the inventory item when the smoke or fog generated containing the carrier nucleic acid including the DNA taggant is released onto the inventory item and/or person.
- DNA is the carrier nucleic acid included in the marker smoke fluid of the security smoke or fog generator to mark an inventory item and/or a person in the vicinity of the inventory item when the smoke or fog is generated.
- nucleic acids such as, for example, RNA or a DNA:RNA hybrid may be used as the carrier nucleic acid containing the DNA taggant in the smoke fluid instead of or in addition to DNA as the carrier nucleic acid.
- the DNA taggant included in the carrier nucleic acid may comprise one specific nucleic acid sequence or alternatively, may comprise a plurality of various nucleic acid sequences.
- polymorphic DNA fragments of the type short tandem repeats (STR) or single nucleotide polymorphisms (SNP) are utilized as an anti-counterfeit nucleic acid tag. While the use of a single sequence for a DNA taggant may make detection of the marker easier and quicker, the use of a plurality of nucleic acid sequences such as STR and SNP, in general, give a higher degree of confidence in a positive identification.
- the nucleic acid concentration may vary from pico grams per liter (1 ⁇ 10 ⁇ 12 gram/L) to micro grams per liter (1 ⁇ 10 ⁇ 9 gram/L). In certain embodiments, the DNA concentration may range from 1 ppb (parts per billion) to 500,000 ppb (i.e. 500 ppm).
- An important feature of the carrier nucleic acid is to protect the DNA taggant having the uniquely identifiable sequence from UV and other influences that may cause degradation over time.
- the carrier nucleic acid is derived from DNA extracted from a specific plant source and rendered non-functional with scrambled sequences.
- the DNA may be specifically digested and ligated to generate artificial nucleic acid sequences which are unique and previously unknown to the world.
- the digestion and ligation of the extracted DNA is completed by standard restriction digestion and ligase techniques known to those skilled in the art of molecular biology.
- the taggant can be encapsulated into materials for protection against UV and degradation.
- the DNA encapsulant material can be any suitable encapsulant material, such as for instance an encapsulant material of plant origin.
- the DNA taggant when the DNA taggant can be encapsulated and suspended in a solvent solution (aqueous or organic solvent solution) producing a “stock” DNA taggant solution at a specified concentration.
- This stock DNA taggant solution can then easily be added to carrier nucleic acid at an appropriate concentration for incorporation into a marker smoke fluid or marker fog fluid.
- the DNA taggant maybe mixed with other components without any prior encapsulation.
- Several processes such as nucleic acid fragment encapsulation and other techniques utilized for protecting nucleotides, and in particular, DNA from degradation, are well known in the art.
- the carrier nucleic acid can camouflage or “hide” the specified nucleic acid tag with extraneous and nonspecific nucleic acid oligomers or fragments, thus making it difficult for unauthorized individuals to identify the sequence of the DNA taggant.
- the carrier nucleic acid comprises a specified double stranded DNA of known sequence from a known source (e.g. mammal, invertebrate, plant sources and the like) along with genomic DNA from the corresponding or similar DNA source.
- a known source e.g. mammal, invertebrate, plant sources and the like
- genomic DNA from the corresponding or similar DNA source.
- the amount of the DNA taggant to be incorporated into a carrier nucleic acid varies depending on the particular marker smoke to be used and the setting where the marker smoke generator is to be deployed, the duration that the taggant needs to be viable (e.g. 1 day, 1 month, 1 year, multiple years) prior to identification, expected environmental exposure, the detection method to be utilized, and so forth.
- carrier nucleic acid containing the DNA taggant with a uniquely identifiable sequence After carrier nucleic acid containing the DNA taggant with a uniquely identifiable sequence has been manufactured or isolated, the preparation of carrier nucleic acid containing the DNA taggant is then mixed with the smoke fluid and then the mixture is stored in the reservoir of the smoke or fog generator.
- the marker smoke fluid mixture including the carrier nucleic acid and the DNA taggant is then converted by the smoke generator to produce a marker smoke comprising the carrier nucleic acid and the DNA taggant so as to cause the marker smoke to flow over the inventory item and any person in the vicinity of the inventory item, the person having an exposed item of clothing and/or an exposed body surface, and thereby to detectably mark the inventory item with the DNA taggant, and detectably mark the exposed item of clothing and/or the exposed body surface of any person present in the vicinity of the inventory item and within range of the marker smoke with the DNA taggant having a uniquely identifiable sequence.
- the carrier nucleic acid containing the DNA taggant having a uniquely identifiable sequence that is included in the marker smoke can then be detected, recovered and authenticated from the inventory item and/or person exposed to the marker smoke using the following techniques discussed below.
- PCR is an useful technique for detection of the DNA taggant as described below.
- the copy number of DNA taggant in a predetermined sample size of carrier nucleic acid used in marker smoke fluid is about 3 copies to about 100,000 copies, more usually about 10 copies to about 50,000 copies, and even more usually about 100 copies to about 10,000 copies of DNA taggant.
- concentration of carrier nucleic acid including the DNA taggant incorporated into the smoke fluid of the security smoke or fog generator may be varied as required depending upon particular embodiments of the invention.
- the placement or position of the DNA taggant on the human body of a person and/or on the inventory item of interest maybe located by the detection of materials or compounds configured to be optically detectable and may be associated with the DNA taggant in the carrier nucleic acid.
- the DNA taggant may be bound or coupled to, or otherwise associated with, a chemically or optically detectable label. Detection of DNA-labeled portions of the item may be carried out by optically detecting fluorescent dyes or upconverting phosphor particles which can be detected easily by UV and/or IR portable light sources.
- a hair sample, clothing sample or a sample from the inventory item could be examined with a UV or IR light source to find a particular region or regions of the sample (e.g., hair sample, clothing sample or a sample from the inventory item) that contain a particular fluorescent marker.
- a particular region or regions of the sample e.g., hair sample, clothing sample or a sample from the inventory item
- only a small portion of the item (as identified by the fluorescent dye or particles) needs to be sampled for detection of the DNA taggant sequence.
- the materials or compounds utilized for locating the position of the carrier DNA on the sample of interest maybe coated with functional groups which can covalently bind to the carrier nucleic acid and the DNA taggant, as described below.
- analyzing the collected sample for the presence of DNA taggant may include, for example, providing a “detection molecule” configured to detect the DNA taggant.
- the detection molecule can be, but is not limited to a nucleic acid probe and/or primer set which is complementary to the sequence of the DNA taggant, or a dye label or color producing molecule configured to selectively bind and adhere to the DNA taggant, for instance by being covalently linked to a sequence of bases to at least a portion of the uniquely identifiable sequence of the DNA taggant.
- the detection molecule(s) are primers which specifically bind to a certain sequence of the DNA taggant.
- an identifiable nucleotide probe may also be provided to enhance the detection of the DNA taggant as well as provide semi-quantitative or quantitative authentication results.
- Various embodiments utilize a wide range of detection methods besides for PCR and real time PCR, such as fluorescent probes, probes configured to molecules which allow for the detection of the nucleic acid tag when bound to the probe by Raman spectroscopy, infrared spectroscopy or other spectroscopic techniques used by those skilled in the art of nucleic acid detection.
- the results of the analysis of the collected sample are then analyzed to determine if the specific DNA taggant was detected in the sample. If the specific DNA taggant is detected in the sample, the collected sample of the inventory item is authenticated as genuine. If the DNA taggant is detected in the collected sample of interest, the conclusion from the analysis is that person is not a match or cannot be verified as present during the activation of the marker smoke or fog machine.
- the DNA taggant may be linked to or otherwise associated with an optical reporter material for quick detection of the position of the carrier nucleic acid containing the DNA taggant on the article of clothing or exposed skin or hair of the a person of interest or on an inventory item.
- DNA is extracted from DNA labeled objects and subjected to PCR amplification with specific primers to produce amplicons that can be analyzed by any of a number of well known means such as for instance by either gel electrophoresis or capillary electrophoresis.
- RT-PCR amplification and detection by fluorescent reporters or any suitable detection means known in the art may be used to obtain results within a very short period of time.
- the quantity or concentration of the DNA taggant within the carrier nucleic acid in a collected sample can be determined and compared to the initial amount of carrier nucleic acid containing the DNA taggant placed in the product to allow for the detection of fraud caused by diluting the product with inferior products by forgers.
- quantitative detection methods comprise providing an internal or external control to evaluate the efficiency of detection from one sample/analysis to the next. The efficiency of detection may be affected by many parameters such as, probe hybridization conditions, molecules or substances in the product which may interfere with detection, and/or primer integrity, enzyme quality, temperature variations for detection methods utilizing PCR.
- any variable conditions can be normalized to obtain an accurate final concentration of the DNA taggant in the carrier nucleic acid present on the product.
- the carrier nucleic acid that includes the DNA taggant is labeled with at least one compound or “detection molecule” prior to being incorporated into the smoke fluid in the extraction and/or detection of the carrier nucleic acid from an inventory item or a sample from the person of interest who may have been exposed to the marker smoke including the carrier nucleic acid containing the DNA taggant.
- a detection molecule is a molecule or compound with at least one functionality.
- fluorescent molecules which may be in particulate form (e.g. an upconverting phosphor: UCP), may be configured to the carrier nucleic acid for certain detection methods which are described in detail below.
- suitable dyes include, but are not limited to, coumarin dyes, xanthene dyes, resorufins, cyanine dyes, difluoroboradiazaindacene dyes (BODIPY), ALEXA dyes, indoles, bimanes, isoindoles, dansyl dyes, naphthalimides, phthalimides, xanthenes, lanthanide dyes, rhodamines and fluoresceins.
- certain visible and near IR dyes and IR materials are known to be sufficiently fluorescent and photostable to be detected as single molecules.
- the visible dye, BODIPY R6G (525/545), and a larger dye, LI-COR's near-infrared dye, IRD-38 (780/810) can be detected with single-molecule sensitivity and can be used to practice the authentication process described herein.
- suitable dyes include, but are not limited to, fluorescein, 5-carboxyfluorescein (FAM), rhodamine, 5-(2′-aminoethyl) aminonapthalene-1-sulfonic acid (EDANS), anthranilamide, coumarin, terbium chelate derivatives, Reactive Red 4, BODIPY dyes and cyanine dyes.
- linking moieties and methodologies for attaching fluorophore or visible dye moieties to nucleotides there are many suitable linking moieties and methodologies for attaching fluorophore or visible dye moieties to nucleotides, as exemplified by the following references: Eckstein, editor, Oligonucleotides and Analogues: A Practical Approach (IRL Press, Oxford, 1991); Zuckerman et al., Nucleic Acids Research, 15: 5305-5321 (1987) (3′ thiol group on oligonucleotide); Sharma et al., Nucleic Acids Research, 19: 3019 (1991) (3′ sulfhydryl); Giusti et al., PCR Methods and Applications, 2: 223-227 (1993) and Fung et al., U.S. Pat. No.
- a nucleic acid probe complementary to the DNA taggant within the carrier nucleic acid is labeled with at least one compound or molecule with functionality to aid in the detection of the carrier nucleic acid or the DNA taggant.
- the techniques and dyes utilized in labeling the nucleic acid tag or the complementary probe are the same due to the nucleic acid nature of the tag and probe.
- the detection molecules of the invention can be incorporated into probe motifs, such as Taqman probes (Held et al., Genome Res. 6: 986-994 (1996), Holland et al., Proc. Nat. Acad. Sci. USA 88: 7276-7280 (1991), Lee et al., Nucleic Acids Res. 21: 3761-3766 (1993)), molecular beacons; Tyagi et al., Nature Biotechnol., 16:49-53 (1998), U.S. Pat. No. 5,989,823, issued Nov.
- probe motifs such as Taqman probes (Held et al., Genome Res. 6: 986-994 (1996), Holland et al., Proc. Nat. Acad. Sci. USA 88: 7276-7280 (1991), Lee et al., Nucleic Acids Res. 21: 3761-3766 (1993)), molecular beacons; Tyagi et al., Nature Biotechnol.
- PNA peptide nucleic acid
- the molecular beacon system is utilized to detect and quantify the DNA taggant from the item of interest.
- “Molecular beacons” are hairpin-shaped nucleic acid detection probes that undergo a conformational transition when they bind to their target that enables the molecular beacons to be detected.
- the loop portion of a molecular beacon is a probe nucleic acid sequence which is complementary to the target nucleic acid to be detected.
- the stem portion of the molecular beacon is formed by the annealing of arm sequences of the molecular beacon that are present on either side of the probe sequence.
- a functional group such as a fluorophore (e.g.
- a quencher molecule such as a nonfluorescent quencher (e.g. DABCYL) is covalently attaches to the end of the other arm.
- a quencher molecule such as a nonfluorescent quencher (e.g. DABCYL) is covalently attaches to the end of the other arm.
- the molecular beacon when the molecular beacon binds to their specified DNA taggant target, a conformational change occurs to the molecular beacon such that the stem and loop structure cannot be formed, thus increasing the distance between the functional group and the quencher which enables the presence of the DNA taggant target to be detected.
- the functional group is a fluorophore
- the binding of the molecular beacon to the DNA taggant is detected by fluorescence spectroscopy.
- a plurality of nucleic acid tags with varying sequences are used in labeling a particular product.
- the different DNA taggants can be detected quantitatively by a plurality of molecular beacons, each with a different colored fluorophore and with a unique probe sequence complementary to at least one of the plurality of nucleic acid tags. Being able to quantitate the various fluorophores (e.g. various DNA taggants) provides a higher level of confidence of identification.
- the other functional groups described above useful in labeling nucleic acid probes can also be utilized in molecular beacons for the present invention.
- the methods for authenticating an inventory item or sample from a person of interest may comprise labeling the item with an optical reporter marker linked to a carrier nucleic acid containing a DNA taggant, detecting the optical reporter, and then characterizing or verifying the DNA taggant associated with the item in an effective manner, by nucleic acid sequencing, hybridization or other such techniques.
- an optical reporter marker having a nucleic acid taggant linked to an optical reporter particle, the carrier nucleic acid containing a DNA taggant having a known portion of its sequence identifiable or sequenceable.
- the optical reporter is included in the marker smoke fluid but is not linked to the carrier nucleic acid containing the DNA taggant.
- the optical reporter particle may be, for example, a light emitting optical reporter such as, for example, an upconverting phosphor particle (UCP).
- UCP upconverting phosphor particle
- the upconverting phosphor particle UCP is coated with a silylation composition which is configured to be covalently linked to the carrier nucleic acid including the DNA taggant.
- UCPs and other optical reporters such as those described in U.S. patent application Ser. No. 11/954,038, filed Dec. 11, 2007, U.S. patent application Ser. No. 11/954,051, filed Dec. 11, 2007, U.S. patent application Ser. No. 11/954,030, filed on Dec. 11, 2007, and U.S. patent application Ser. No. 11/954,055, filed on Dec.
- the optical reporter used in combination with the carrier nucleic acid may be an ultraviolet (UV) taggant, a long UV marker or a UV fluorophore.
- the optical reporter used in combination with the carrier nucleic acid may supplemented or replaced by a protein, and/or a trace element.
- the optical reporter compound may be produced as a solid or liquid, water or oil based, a suspension, an aggregate or the like.
- the optical reporter marker allows for easy detection of where the optical reporter marker is located on or within the item of interest with basic high intensity light emitting equipment such as a hand-held ultraviolet (UV) lamp, IR emitting diode, hand-held IR laser and the like.
- basic high intensity light emitting equipment such as a hand-held ultraviolet (UV) lamp, IR emitting diode, hand-held IR laser and the like.
- the optical reporter marker also enables the authentication of the item of interest by both confirming that the correct emission spectra/wavelength for the optical reporter particle is detected as well as being able to locate and determine by sequencing if the DNA taggant comprises the correct uniquely identifiable nucleic acid sequence.
- the nucleic acid-linked optical reporter marker which includes the nucleic acid-linked optical reporter marker may be mixed with the marker smoke fluid of a security/marker smoke or fog for authenticating an inventory item of interest or a sample collected from a person of interest.
- the nucleic acid-linked optical reporter marker may be applied in a specific, pre-determined amount or quantity.
- the marker is may be applied in the form of a dense smoke or fog which is emitted from the security smoke or fog generator due to activation of the heat generator of the security/marker smoke or fog generator.
- a heater element in the security/marker smoke or fog generator may be activated by a triggering event such as, e.g., a security alarm to convert liquid glycerol of the marker smoke fluid into an extremely dense artificial smoke or fog which includes the optical reporter marker and which is immediately spread throughout the area including on a exposed areas of a person (e.g., hair, skin, nostrils, and/or clothing) in the vicinity of the fog generator and on inventory items located in the area.
- a triggering event such as, e.g., a security alarm to convert liquid glycerol of the marker smoke fluid into an extremely dense artificial smoke or fog which includes the optical reporter marker and which is immediately spread throughout the area including on a exposed areas of a person (e.g., hair, skin, nostrils, and/or clothing) in the vicinity of the fog generator and on inventory items located in the area.
- exposed areas of the person and/or the inventory item may be marked with the nucleic acid-linked optical reporter marker and the nucleic acid-linked optical reporter emitted in the dense fog may then later be used for authentication purposes to determine whether the person of interest was at the location of the security/marker smoke or fog generator and/or whether the item was also at that location at the time of activation of the security/marker smoke or fog generator.
- the detecting of the optical reporter marker associated with the item occurs after a period of time has lapsed.
- the item may be introduced into a supply chain or the item may be placed into service. Having a method in which the original owner can track and authenticate items or goods allows for a better monitoring of when and where stolen goods are being sold.
- Detecting the optical reporter particle(s) represents a first level of authentication of the item of interest.
- the marker can be detected by a high energy invisible light source such as an infrared laser, which may be hand-held and manipulated by a user, or suitably mounted to allow goods to be positioned in the lamp output.
- the infrared light is absorbed by the optical reporter particles, which in turn emit light at a wavelength that is characteristic of the optical reporter particle.
- UCP upconverting phosphor
- a sample is collected from the item of interest having the optical reporter marker as described below.
- this may comprise visually inspecting the item for an optical reporter signal under the appropriate illumination, and/or scraping, cutting or dissolving a portion of the marked item to obtain a sample for more detailed analysis.
- the collecting of the sample may be carried out, for example, by wiping the item with a cloth or cotton swab (which may be moistened with solvent) to recover the optical reporter marker and associated DNA taggant from the item.
- the optical reporter marker may be recovered from the item using, for example, medical tape.
- sample collection may be achieved using a cutting, gouging, scraping, abrading, or other such sampling methods, for instance with tool configured to remove a portion of the item containing the optical reporter marker.
- the collected sample may then be analyzed for the presence of the carrier nucleic acid that includes the DNA taggant having a uniquely identifiable sequence.
- the collected sample are can be analyzed by determining the DNA sequence of the DNA taggant, and comparing the determined DNA sequence with a known or reference DNA sequence of the DNA taggant.
- the analysis of the sample collected from the item may occur without further purification, but in many embodiments some form of extraction, isolation or purification of the nucleic acid tag obtained in the sample may be required. Details on the extraction, concentration and purification techniques useful for the methods of the invention are described more fully below and also in the examples.
- analyzing the sample includes providing a “detection molecule” complementary to the DNA taggant.
- a detection molecule includes but is not limited to a nucleic acid probe and/or primer set which is complementary to at least a portion of the sequence of the DNA taggant, or a dye label or color-producing molecule configured to bind and adhere to the DNA taggant.
- the detection of the nucleic acid taggant may further comprise amplifying the DNA taggant using PCR, with the detection molecule(s) being primers which specifically bind to a certain sequence of the nucleic acid taggant.
- an identifiable nucleotide probe may also be provided to enhance the detection of the nucleic acid taggant as well as provide semi-quantitative or fully quantitative authentication results.
- results from the analysis of the sample can be completed within 30 minutes to two hours, including extracting or purifying the nucleic acid taggant from the collected sample.
- Various embodiments of the invention may utilize a wide range of detection methods besides for PCR and real time PCR, such as DNA microarray, fluorescent probes, probes configured to molecules which allow for the detection of the nucleic acid tag when bound to the probe by Raman spectroscopy, Infrared spectroscopy or other spectroscopic techniques used by those skilled in the art of nucleic acid detection.
- the method utilized to detect the nucleic acid is dependent on the quantity of nucleic acid taggant associated with the optical reporter marker. When only a few copies of NA taggant are collected in the marker sample, high sensitivity techniques such as PCR may be preferable over fluorescent probes.
- the results of the analysis of the collected sample are reviewed and a query or determination is made as to whether or not the specific nucleic acid taggant was detected in the sample. If the DNA taggant is not found or not detected in the collected sample of the item of interest, the conclusion from the analysis is the that item is not a match. If the DNA taggant is detected in the sample, then the item is verified as being authentic and thus a match.
- the quantity or concentration of the nucleic acid taggant within a collected sample can be determined and compared to the initial amount of carrier nucleic acid placed in the item to allow for the detection of fraud caused by diluting the item with inferior products by forgers.
- quantitative detection would further comprise, providing an internal or external control to evaluate the efficiency of detection from one sample/analysis to the next.
- the efficiency of detection may be affected by many parameters such as, probe hybridization conditions, molecules or substances in the good which may interfere with detection, and/or primer integrity, enzyme quality, temperature variations for detection methods utilizing PCR.
- any variable conditions can be normalized to obtain an accurate final concentration of the carrier nucleic acid in the item.
- a plurality of DNA taggants with varying sequences associated with a corresponding plurality of optical reporters may be used in labeling a single item.
- the different nucleic acid tags can be detected qualitatively by the plurality of optical reporters, each with a different emission wavelength linked to a DNA taggant having a uniquely identifiable sequence.
- the carrier nucleic acid is incorporated into the product in the presence of molecules which encapsulate the carrier nucleic acid by forming microspheres.
- Encapsulating the carrier nucleic acid has the benefit of preventing or at least inhibiting or delaying the degradation of the carrier nucleic acid before recovery for testing or analysis.
- the materials used in encapsulating can in some embodiments be of plant origin, but can also be synthetically produced materials.
- the encapsulation of a carrier nucleic acid includes incorporating the carrier nucleic acid into a solvent with a polymer configured to form a microsphere around the carrier nucleic acid which harbors the DNA taggant.
- the polymers used can be selected from biodegradable or non-biodegradable polymers.
- Suitable biodegradable polymers are those such as lactic and glycolic acids and esters such as polyanhydrides, polyurethantes, butryic polyacid, valeric polyacid, and the like.
- Non-biodegradable polymers appropriate for encapsulation are vinyletylenene acetate and acrylic polyacid, polyamides and copolymers as a mixture thereof.
- the polymers can also be selected from natural compounds such as dextran, cellulose, collagen, albumin, casein and the like.
- Certain aspects of the invention comprise labeling the microspheres to benefit in the capture of the nucleic acid tag during the extraction of the label from the product of interest.
- the microspheres may comprise magnetically charged molecules which allow the microspheres containing the nucleic acid tag to be pulled out of a solution by a magnet.
- microspheres can also be labeled with streptavidin, avidin, biotinylated compounds and the like. Labeling the microspheres aids in the purification of the nucleic acid tag prior to detection and also is useful in concentrating the nucleic acid tag so as to enable in some embodiments, the nucleic acid tag to be detected without PCR amplification.
- nucleic acid extraction solutions have been developed over the years for extracting nucleic acid sequences from a sample of interest. See, for example, Sambrook et al. (Eds.) Molecular Cloning, (1989) Cold Spring Harbor Press. Many such methods typically require one or more steps of, for example, a detergent-mediated step, a protease treatment step, a phenol and/or chloroform extraction step, and/or an alcohol precipitation step.
- Some nucleic acid extraction solutions may comprise an ethylene glycol-type reagent or an ethylene glycol derivative to increase the efficiency of nucleic acid extraction while other methods only use grinding and/or boiling the sample in water. Other methods, including solvent-based systems and sonication, could also be utilized in conjunction with other extraction methods.
- the authentication process includes capturing the nucleic acid tag directly with a complementary hybridization probe attached to a solid support.
- the methods for capturing the nucleic acid tag involve a material in a solid-phase interacting with reagents in the liquid phase.
- the nucleic acid probe is attached to the solid phase.
- the nucleic acid probe can be in the solid phase such as immobilized on a solid support, through any one of a variety of well-known covalent linkages or non-covalent interactions.
- the support is comprised of insoluble materials, such as controlled pore glass, a glass plate or slide, polystyrene, acrylamide gel and activated dextran.
- the support has a rigid or semi-rigid character, and can be any shape, e.g. spherical, as in beads, rectangular, irregular particles, gels, microspheres, or substantially flat support.
- it can be desirable to create an array of physically separate sequencing regions on the support with, for example, wells, raised regions, dimples, pins, trenches, rods, pins, inner or outer walls of cylinders, and the like.
- suitable support materials include, but are not limited to, agarose, polyacrylamide, polystyrene, polyacrylate, hydroxethylmethacrylate, polyamide, polyethylene, polyethyleneoxy, or copolymers and grafts of such.
- Other embodiments of solid-supports include small particles, non-porous surfaces, addressable arrays, vectors, plasmids, or polynucleotide-immobilizing media.
- a nucleic acid probe can be attached to the solid support by covalent bonds, or other affinity interactions, to chemically reactive functionality on the solid-supports.
- the nucleic acid can be attached to solid-supports at their 3′, 5′, sugar, or nucleobase sites.
- the 3′ site for attachment via a linker to the support is preferred due to the many options available for stable or selectively cleavable linkers.
- Immobilization is preferably accomplished by a covalent linkage between the support and the nucleic acid.
- the linkage unit, or linker is designed to be stable and facilitate accessibility of the immobilized nucleic acid to its sequence complement.
- non-covalent linkages such as between biotin and avidin or streptavidin are useful.
- other functional group linkers include ester, amide, carbamate, urea, sulfonate, ether, and thioester.
- a 5′ or 3′ biotinylated nucleotide can be immobilized on avidin or streptavidin bound to a support such as glass.
- the tag can be detected quantitatively without being amplified by PCR.
- a single stranded DNA taggant labeled with a detection molecule i.e. fluorophore, biotin, etc.
- a detection molecule i.e. fluorophore, biotin, etc.
- the DNA taggant can also be double stranded (dsDNA), with at least one strand being labeled with a detection molecule.
- the taggant In the case of a dsDNA taggant, the taggant must be heated sufficiently to melt the double stranded structure and then quick cooled to produce single stranded DNA, where at least one of the strands configured with a detection molecule is capable of hybridizing to the complementary DNA probe under appropriate annealing or hybridization conditions.
- the complementary probe is labeled with a detection molecule and allowed to hybridize to a strand of the DNA taggant.
- the hybridization of the probe can be completed within the garment or can be completed after the DNA taggant/carrier nucleic acid containing the DNA taggant has been extracted from the product.
- the direct detection methods described herein depend on having a large initial concentration of nucleic acid label embedded into the pieces of clothing or rigorous extraction/capture methods which concentrate the nucleic acid tag extracted from a large volume or mass of a particular product.
- the extraction of the DNA taggant varies depending on the garment being authenticated.
- the carrier nucleic acid and DNA taggant are linked to one or more UCP particles, the carrier nucleic acid and DNA taggant can be located by detecting the presence of the UCP by an appropriate light source.
- the DNA taggant can then be extracted from the item by scraping, cutting out, or dissolving the portion of the garment which is determined to have the presence of the correct up-converting phosphor particle(s).
- the DNA taggant may isolated and/or amplified by PCR using techniques known to those skilled in the art.
- the authentication process comprises amplifying the nucleic tag by polymerase chain reaction.
- conventional PCR amplification is not a quantitative detection method.
- primer dimers and other extraneous nucleic acids are amplified together with the nucleic acid corresponding to the analyte.
- These impurities must be separated, usually with gel separation techniques, from the amplified product resulting in possible losses of material.
- methods are known in which the PCR product is measured in the log phase, these methods require that each sample have equal input amounts of nucleic acid and that each sample amplifies with identical efficiency, and are therefore, not suitable for routine sample analyses.
- quantitative competitive PCR amplification uses an internal control competitor and is stopped only after the log phase of product formation has been completed.
- PCR is used to amplify DNA in a sample in the presence of a non-extendable dual labeled fluorogenic hybridization probe.
- One fluorescent dye serves as a reporter and its emission spectra is quenched by the second fluorescent dye.
- the method uses the 5′ nuclease activity of Taq polymerase to cleave a hybridization probe during the extension phase of PCR. The nuclease degradation of the hybridization probe releases the quenching of the reporter dye resulting in an increase in peak emission from the reporter. The reactions are monitored in real time.
- RT-PCR Reverse transcriptase-real time PCR
- Numerous commercially thermal cyclers are available that can monitor fluorescent spectra of multiple samples continuously in the PCR reaction, therefore the accumulation of PCR product can be monitored in ‘real time’ without the risk of amplicon contamination of the laboratory. Heid, C. A.; Stevens, J.; Livak, K. L.; Williams, P. W. (1996). Real time quantitative PCR. Gen. Meth. 6: 986-994.
- real time PCR detection strategies may be used, including known techniques such as intercalating dyes (e.g. ethidium bromide) and other double stranded DNA binding dyes used for detection (such as SYBR green, a highly sensitive fluorescent stain obtainable from FMC Bioproducts), dual fluorescent probes (Wittwer, C. et al., (1997) Bio-Techniques 22: 176-181) and panhandle fluorescent probes (i.e. molecular beacons; Tyagi S., and Kramer FR. (1996) Nature Biotechnology 14: 303-308).
- intercalating dyes e.g. ethidium bromide
- other double stranded DNA binding dyes used for detection such as SYBR green, a highly sensitive fluorescent stain obtainable from FMC Bioproducts
- dual fluorescent probes i.e. molecular beacons; Tyagi S., and Kramer FR. (1996) Nature Biotechnology 14: 303-308.
- intercalating dyes and double stranded DNA binding dyes permit quantitation of PCR product accumulation in real time applications, they suffer from the previously mentioned lack of specificity, detecting primer dimer and any non-specific amplification product. Careful sample preparation and handling, as well as careful primer design, using known techniques must be practiced to minimize the presence of matrix and contaminant DNA and to prevent primer dimer formation. Appropriate PCR instrument analysis software and melting temperature analysis permit a means to extract specificity and may be used with these embodiments.
- PCR amplification is performed in the presence of a non-primer detectable probe which specifically binds the PCR amplification product, i.e., the amplified detector DNA moiety.
- PCR primers are designed according to known criteria and PCR may be conducted in commercially available instruments.
- the probe is preferably a DNA oligonucleotide specifically designed to bind to the amplified detector molecule.
- the probe preferably has a 5′ reporter dye and a downstream 3′ quencher dye covalently bonded to the probe, which allows fluorescent resonance energy transfer.
- Suitable fluorescent reporter dyes include 6-carboxy-fluorescein (FAM), tetrachloro-6-carboxy-fluorescein (TET), 2,7-dimethoxy-4,5-dichloro-6-carboxy-fluorescein (JOE) and hexachloro-6-carboxy-fluorescein (HEX).
- a suitable reporter dye is 6-carboxy-tetramethyl-rhodamine (TAMRA). These dyes are commercially available from Perkin-Elmer. Detection of the PCR amplification product may occur at each PCR amplification cycle. At any given cycle during the PCR amplification, the amount of PCR product is proportional to the initial number of template copies.
- the number of template copies is detectable by fluorescence of the reporter dye.
- the reporter dye When the probe is intact, the reporter dye is in proximity to the quencher dye which suppresses the reporter fluorescence.
- the DNA polymerase cleaves the probe in the 5′-3′ direction separating the reporter dye from the quencher dye increasing the fluorescence of the reporter dye which is no longer in proximity to the quencher dye. The increase in fluorescence is measured and is directly proportional to the amplification during PCR.
- This detection system is now commercially available as the TaqMan® PCR system from Perkin-Elmer, which allows real time PCR detection.
- the reporter dye and quencher dye may be located on two separate probes which hybridize to the amplified PCR detector molecule in adjacent locations sufficiently close to allow the quencher dye to quench the fluorescence signal of the reporter dye.
- the 5′-3′ nuclease activity of the polymerase cleaves the one dye from the probe containing it, separating the reporter dye from the quencher dye located on the adjacent probe preventing quenching of the reporter dye.
- detection of the PCR product is by measurement of the increase in fluorescence of the reporter dye.
- Molecular beacons systems are frequently used with real time PCR for specifically detecting the nucleic acid template in the sample quantitatively.
- the Roche Light CyclerTM or other such instruments may be used for this purpose.
- the detection molecule configured to the molecular beacon probe may be visible under daylight or conventional lighting and/or may be fluorescent. It should also be noted that the detection molecule may be an emitter of radiation, such as a characteristic isotope.
- SERS Surface Enhanced Raman Scattering
- Nucleic acid tags and/or nucleic acid probes can be labeled or modified to achieve changes in SERS of the nucleic acid tag when the probe is hybridized to the nucleic acid tag.
- SERS for quantitatively detecting a nucleic acid provides a relatively fast method of analyzing and authenticating a particular product.
- QTL Quencher-Tether-Ligand
- T tethering element
- L ligand
- the QTL system can rapidly and accurately detect and quantify target biological molecules in a sample.
- Suitable examples of ligands that can be used in the polymer-QTL approach include chemical ligands, hormones, antibodies, antibody fragments, oligonucleotides, antigens, polypeptides, glycolipids, proteins, protein fragments, enzymes, peptide nucleic acids and polysaccharides.
- Examples of quenchers for use in the QTL molecule include methyl viologen, quinones, metal complexes, fluorescent dyes, and electron accepting, electron donating and energy accepting moieties.
- the tethering element can be, for example, a single bond, a single divalent atom, a divalent chemical moiety, and a multivalent chemical moiety.
- these examples of the ligands, tethering elements, and quenchers that form the QTL molecule are not to be construed as limiting, as other suitable examples would be easily determined by one of skill in the art.
- kits for authenticating items of interest using the methods of the invention may include, for example, a container enclosing the optical reporter marker, and a sample tube for holding a collected sample of the item or item to be authenticated.
- the kits may also include an applicator for sampling an item.
- the kits may still further include a collection tool for taking a sample of the labeled item for transfer to the sample tube.
- the kits may yet further include a suitable portable light source for detecting the optical reporters.
- the optical reporter marker may be in the form of a liquid solution or dispersion, and the container with the kit would be suitably configured for holding a liquid.
- the applicator of the kit may comprise an “eye-dropper” for applying liquid optical reporter marker solution to the item in droplet form, a spatula for smearing the solution on an item, a syringe for injecting the solution into an item, or like type of applicator.
- the collection tool of the kit may comprise a spoon, gouge, a scraping or abrading tool for removing a sample of the labeled item, a blade or scissors for cutting a piece of the item, a cloth (which may be solvent-moistened) for wiping a sample from the item, or the like.
- the sample tube of the kit may comprise a sealable vial or eppendorf tube, and may contain solvent or solution for extraction of the optical reporter marker from the sample taken from the tagged item.
- the portable light source of the kit may comprise a hand-held UV lamp suitable for detecting the optical reporter marker.
- the kit may further include one or more primers and/or probes as well as solutions appropriate for PCR analysis.
- the kit may further include a PCR instrument for analysis of the extracted optical reporter marker.
- Nucleotide-labeled optical reporters in accordance with the invention can be made by a variety of methods, including those depicted in the co-pending U.S. application “Methods for linking Optical Reporters to Biomolecules,” which is hereby incorporated by reference.
- the taggants used can include, for example, a combination of DNA taggants, and an infrared upconverting phosphor (UCP) reporter.
- the taggants used can include, for example, a combination of DNA taggants, an infrared upconverting phosphor (UCP) reporter and a UV reporter.
- the (UCP) IR reporter can be, for example, a green, a blue or a red (UCP) IR reporter, such as for instance the Green IR Marker, Product No. BPP-1069; the Blue UCP, Product No. BPP-1070; or the Red UCP, Product No. BPP-1071 from Boston Applied Technologies Inc., Woburn, Mass.
- the Green IR Marker such as for instance the Green IR Marker, Product No. BPP-1069; the Blue UCP, Product No. BPP-1070; or the Red UCP, Product No. BPP-1071 from Boston Applied Technologies Inc., Woburn, Mass.
- the objects of interest marked with carrier nucleic acid that incorporates the DNA taggants include, for example, ceramic surfaces, plastic films, vinyl sheets, antiques, items of jewelry, identification cards, credit cards, magnetic strip cards, paintings, artwork, souvenirs, sports collectibles and other collectibles. The authenticity of these objects can then be verified by recovering and identifying the taggants coated thereon through, for example, methods described in further detail below.
- the taggant includes an infrared upconverting phosphor (UCP) taggant and a DNA taggant.
- the taggant can be recovered from the taggant-coated portion of the object without disturbing the appearance of the object.
- the unique taggant is a DNA taggant having a unique DNA sequence and the unique non-natural DNA sequence is stored in a database that matches the unique DNA sequence to the data elements corresponding to the object which is coated with the unique taggant.
- the database can in turn be located on a computer that can be accessed in order to locate, track, authenticate and verify the identity of the tagged object from which the taggant was recovered.
- DNA taggants useful in the examples described below include any suitable DNA taggant, such as for instance, in one embodiment, the DNA taggant is a double stranded DNA oligomer having a length of between about 40 base pairs and about 1000 base pairs. In other embodiments the DNA taggant is a double stranded DNA oligomer with a length of between about 80 and 500 base pairs. In another embodiment the DNA taggant is a double stranded DNA oligomer having a length of between about 100 and about 250 base pairs. Alternatively, the DNA taggant can be single-stranded DNA of any suitable length, such as between about 40 bases and about 1000 bases; between about 80 and 500 bases; or between about 100 and about 250 bases. The DNA taggant can be natural DNA, whether isolated from natural sources or synthetic; or the DNA taggant can be a synthetically produced non-natural sequence. All or a portion of the DNA may comprise an identifiable sequence.
- the DNA taggant is identifiable by any suitable detection and/or identification method such as for example, hybridization with a taggant-sequence specific nucleic acid probe, an in situ hybridization method (including fluorescence in situ hybridization: FISH), amplification using a polymerase chain reaction (PCR), such as quantitative/real time PCR and detection of the amplified sequences (amplicons) by any of the variety of standard well known methods.
- a suitable detection and/or identification method such as for example, hybridization with a taggant-sequence specific nucleic acid probe, an in situ hybridization method (including fluorescence in situ hybridization: FISH), amplification using a polymerase chain reaction (PCR), such as quantitative/real time PCR and detection of the amplified sequences (amplicons) by any of the variety of standard well known methods.
- FISH fluorescence in situ hybridization
- PCR polymerase chain reaction
- the nucleic acid taggants e.g., DNA taggants recovered from the object are amplified by polymerase chain reaction (PCR) and resolved by gel electrophoresis. Since the sequence of the nucleic acid taggants of the present invention are unique and specific to the tagged object, the original nucleic acid will be amplified only by use of primers having specific sequences complementary to a portion of the unique taggant sequence. Through this procedure, if the examined object carries the original nucleic acid, the PCR procedure will amplify extracted nucleic acid to produce amplicons of a predetermined size and a sequence identical to a portion of the original nucleic acid sequence of the taggant.
- PCR polymerase chain reaction
- the sample recovered from the examined object does not include the unique nucleic acid corresponding to the authentic object, there will likely be no amplified nucleic acid product, or if the primers do amplify the recovered nucleic acid to produce one or more random amplicons, these one or more amplicons cannot have the unique taggant nucleic acid sequence of the from the authentic object.
- the random amplicons derived from counterfeit articles are also of random lengths and the likelihood of producing amplicons of the exact lengths specified by the taggant-specific primers is vanishingly small. Therefore, by comparing the sizes and amount of PCR products, the authenticity of labeled objects can be verified, non-authentic objects can be screened and rejected and anti-counterfeit screening purpose is then achieved.
- the number of amplicons amplified and the lengths of the amplicons can be determined after any molecular weight or physical dimension-based separation, such as for instance and without limitation, gel electrophoresis in any suitable matrix medium for example in agarose gels, polyacrylamide gels or mixed agarose-polyacrylamide gels and the electrophoretic separation can be in any suitable format, such as for instance in a slab gel or by capillary electrophoresis.
- the following examples illustrate embodiments of the present invention to mark an inventory item with a marker smoke including a carrier nucleic acid that includes a DNA taggant having a uniquely identifiable sequence.
- carrier nucleic acid 40 mg/mL in deionized water
- carrier nucleic acid 40 mg/mL in deionized water
- 50 uL 0.6 M NaOH solution EMD Millipore Chemicals, ACS grade
- the activated nucleic acid mixture was then transferred to a 15 mL conical plastic test tube (BD Falcon Labware) and 9.9 mL poly-L-lysine (0.1% w/v, Sigma-Aldrich) was added and thoroughly mixed.
- the SmokeCloak fog machine loaded with the marker smoke fluid was placed on the floor adjacent to the open entrance door and turned-on to discharge fog into the room. The door was closed and the smoke was allowed to dissipate for about 5 minutes by which time the marker smoke thinned out sufficiently for the operator to see the location of the test fabrics. No visible change to the fabrics or clothing after exposure to the marker smoke was evident. These fabrics and items of clothing were then collected by the operator and taken to the laboratory for analysis. The collected fabric samples and articles of clothing retrieved from different locations of the room were labeled and stored in sealed plastic bags. All samples were sent to the lab and were forensically authenticated.
- PCR analysis of samples was performed using a primer pair complementary to the uniquely identifiable sequence of the DNA taggant concealed within the carrier nucleic acid present in the marker smoke.
- FIG. 1 shows representative scans obtained by capillary electrophoresis of PCR products from samples taken from a cotton fabric and a woolen fabric retrieved from the room after exposure to the marker smoke.
- Samples from the operator were also collected. Medical tape, skin, coat, and shoes were stripped by attaching and removing medical tape and the pieces of tape were sent to the lab for analysis. The operator's hair and nostrils were swabbed using generic cotton swabs and the swabs submitted for PCR analysis.
- FIG. 2 shows capillary electrophoresis scans of PCR products from samples taken from the operator. Panels show PCR products from sample from the operator immediately after retrieving the fabric and clothing items as described in Example 1.
- A Nasal swab;
- B Swab of exposed skin;
- C Tape after sampling operator's jacket;
- D Tape after sampling operator's shoes.
- Panels show PCR products from sample from the operator (A) Hair sample; (B) Nasal swab; (C) Swab of exposed skin; (D) Tape after sampling operator's shoes.
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/570,242 US10741034B2 (en) | 2006-05-19 | 2014-12-15 | Security system and method of marking an inventory item and/or person in the vicinity |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/437,265 US20070048761A1 (en) | 2005-05-20 | 2006-05-19 | System and method for authenticating multiple components associated with a particular product |
US12/465,450 US20090286250A1 (en) | 2006-05-19 | 2009-05-13 | Incorporating soluble security markers into cyanoacrylate solutions |
US13/652,781 US20140106357A1 (en) | 2012-10-16 | 2012-10-16 | Security system and method of marking an inventory item and/or person in the vicinity |
US13/789,093 US9790538B2 (en) | 2013-03-07 | 2013-03-07 | Alkaline activation for immobilization of DNA taggants |
US14/570,242 US10741034B2 (en) | 2006-05-19 | 2014-12-15 | Security system and method of marking an inventory item and/or person in the vicinity |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/652,781 Continuation-In-Part US20140106357A1 (en) | 2006-05-19 | 2012-10-16 | Security system and method of marking an inventory item and/or person in the vicinity |
Publications (2)
Publication Number | Publication Date |
---|---|
US20150302713A1 US20150302713A1 (en) | 2015-10-22 |
US10741034B2 true US10741034B2 (en) | 2020-08-11 |
Family
ID=54322486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/570,242 Active 2033-07-12 US10741034B2 (en) | 2006-05-19 | 2014-12-15 | Security system and method of marking an inventory item and/or person in the vicinity |
Country Status (1)
Country | Link |
---|---|
US (1) | US10741034B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10921484B2 (en) * | 2017-11-21 | 2021-02-16 | Reliance Core Consulting | Methods and systems for detecting motion corresponding to a field of interest |
US11691165B2 (en) | 2011-10-27 | 2023-07-04 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9904734B2 (en) | 2013-10-07 | 2018-02-27 | Apdn (B.V.I.) Inc. | Multimode image and spectral reader |
CN106103121B (en) | 2014-03-18 | 2019-12-06 | 亚普蒂恩(B.V.I.)公司 | Encrypted optical marker for security applications |
US10745825B2 (en) | 2014-03-18 | 2020-08-18 | Apdn (B.V.I.) Inc. | Encrypted optical markers for security applications |
US9666063B2 (en) * | 2015-04-09 | 2017-05-30 | Google Inc. | Motion sensor adjustment |
FR3048112B1 (en) * | 2016-02-23 | 2020-02-28 | Dominique Mercier | REMANENT LABELING PROCESS BY OLFACTIVE IMPREGNATION |
WO2017180302A1 (en) | 2016-04-11 | 2017-10-19 | Apdn (B.V.I.) Inc. | Method of marking cellulosic products |
US10995371B2 (en) | 2016-10-13 | 2021-05-04 | Apdn (B.V.I.) Inc. | Composition and method of DNA marking elastomeric material |
WO2018156352A1 (en) | 2017-02-21 | 2018-08-30 | Apdn (B.V.I) Inc. | Nucleic acid coated submicron particles for authentication |
US20210402430A1 (en) * | 2020-06-26 | 2021-12-30 | Illinois Tool Works Inc. | Systems and methods for grafting a molecular code onto a material by an atmospheric plasma treatment |
Citations (226)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2428925A (en) | 1944-01-29 | 1947-10-14 | Honeywell Regulator Co | Gyroscope construction |
US4183989A (en) | 1976-12-07 | 1980-01-15 | Portals Limited | Security papers |
US4278557A (en) | 1980-04-15 | 1981-07-14 | The United States Of America As Represented By The Secretary Of The Air Force | Solvent mixture for dissolving and removing epoxy resinous compounds |
US4454171A (en) | 1980-12-08 | 1984-06-12 | Samcoe Holding Corporation | Method for wet processing, drying and moisture conditioning tubular knitted fabric |
EP0140333A2 (en) | 1983-10-28 | 1985-05-08 | Alcatel N.V. | Sound reproducing system |
US4548955A (en) | 1985-02-25 | 1985-10-22 | Sogo Pharmaceutical Company Limited | Nylon capsule responding to pH |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
WO1987006383A1 (en) | 1986-04-09 | 1987-10-22 | Biotal Limited | Labelling articles it is wished to authenticate |
US4739044A (en) | 1985-06-13 | 1988-04-19 | Amgen | Method for derivitization of polynucleotides |
US4757141A (en) | 1985-08-26 | 1988-07-12 | Applied Biosystems, Incorporated | Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof |
US4849208A (en) | 1984-01-30 | 1989-07-18 | Enzo Biochem, Inc. | Detectable molecules, method of preparation and use |
US4861620A (en) | 1986-11-14 | 1989-08-29 | Mitsubishi Denki Kabushiki Kaisha | Method of laser marking |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
WO1990014441A1 (en) | 1989-05-22 | 1990-11-29 | Cetus Corporation | Methods for tagging and tracing materials with nucleic acids |
US5047519A (en) | 1986-07-02 | 1991-09-10 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
US5075216A (en) | 1988-09-23 | 1991-12-24 | Cetus Corporation | Methods for dna sequencing with thermus aquaticus dna polymerase |
US5089691A (en) | 1989-07-11 | 1992-02-18 | Brother Kogyo Kabushiki Kaisha | Image recording apparatus having bar code reader for reading bar code attached to leading end of microcapsule sheet |
WO1992004469A2 (en) | 1990-09-06 | 1992-03-19 | Imperial Chemical Industries Plc | Nucleic acid detection method using particle agglutination |
US5132242A (en) | 1987-07-15 | 1992-07-21 | Cheung Sau W | Fluorescent microspheres and methods of using them |
US5139812A (en) | 1989-07-07 | 1992-08-18 | Bioprobe Systems | Method and apparatus for high security crypto-marking for protecting valuable objects |
US5151507A (en) | 1986-07-02 | 1992-09-29 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
US5156765A (en) | 1990-05-15 | 1992-10-20 | Fox Valley Systems, Inc. | Aerosol foam marking compositions |
US5176203A (en) | 1989-08-05 | 1993-01-05 | Societe De Conseils De Recherches Et D'applications Scientifiques | Apparatus for repeated automatic execution of a thermal cycle for treatment of samples |
US5270183A (en) | 1991-02-08 | 1993-12-14 | Beckman Research Institute Of The City Of Hope | Device and method for the automated cycling of solutions between two or more temperatures |
JPH06187239A (en) | 1992-12-18 | 1994-07-08 | Nippon Telegr & Teleph Corp <Ntt> | Data coincidence control system for multi-layered cache memory |
EP0623658A2 (en) | 1993-05-05 | 1994-11-09 | Imperial Chemical Industries Plc | Indelible ink formation |
WO1995002702A1 (en) | 1993-07-12 | 1995-01-26 | James Howard Slater | A security device using an ultrasensitive microtrace for protecting materials, articles and items |
WO1995006249A1 (en) | 1993-08-20 | 1995-03-02 | Biocode, Inc. | Marking of products to establish identity and source |
US5415839A (en) | 1993-10-21 | 1995-05-16 | Abbott Laboratories | Apparatus and method for amplifying and detecting target nucleic acids |
US5498283A (en) | 1994-08-23 | 1996-03-12 | Scitex Digital Printing, Inc. | Waterfast security inks |
US5508197A (en) | 1994-07-25 | 1996-04-16 | The Regents, University Of California | High-speed thermal cycling system and method of use |
US5595871A (en) | 1993-08-25 | 1997-01-21 | University Of Scranton | Detection and prevention of mycoplasma hominis infection |
US5599578A (en) | 1986-04-30 | 1997-02-04 | Butland; Charles L. | Technique for labeling an object for its identification and/or verification |
WO1997004392A1 (en) | 1995-07-19 | 1997-02-06 | International Business Machines Corporation | Shared cache memory device |
US5602381A (en) | 1993-05-19 | 1997-02-11 | Nhk Spring Co., Ltd. | Objects to be checked for authenticity, and method and apparatus for checking whether or not objects are authentic |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5643728A (en) | 1992-08-26 | 1997-07-01 | Slater; James Howard | Method of marking a liquid |
RU2084535C1 (en) | 1995-11-29 | 1997-07-20 | Галина Филиповна Сиволобова | Method of marking and identification of valuable documents |
WO1997045539A1 (en) | 1996-05-31 | 1997-12-04 | Mikael Kubista | Probe for analysis of nucleic acids |
WO1998006084A1 (en) | 1996-08-02 | 1998-02-12 | Beijing Sanzhu Xinda Biological Probe Co., Ltd. | A method of nucleic acid code analystic technique used in falseproof label |
US5736314A (en) | 1995-11-16 | 1998-04-07 | Microfab Technologies, Inc. | Inline thermo-cycler |
WO1998016313A1 (en) | 1996-10-12 | 1998-04-23 | Central Research Laboratories Limited | Heating apparatus |
EP0840350A2 (en) | 1996-11-04 | 1998-05-06 | Applied Materials, Inc. | Plasma apparatus and process with filtering of plasma sheath-generated harmonics |
GB2319337A (en) | 1996-11-12 | 1998-05-20 | Probe Fx Patents Limited | Composition for applying to goods as tracer or identifier |
US5776713A (en) | 1988-02-02 | 1998-07-07 | Biocode Ltd. | Marking of products to establish identity and source |
US5866336A (en) | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
US5912257A (en) | 1995-09-06 | 1999-06-15 | The Research Foundation Of State University Of New York | Two-photon upconverting dyes and applications |
US5942444A (en) | 1997-01-27 | 1999-08-24 | Biocode, Inc. | Marking of products to establish identity, source and fate |
WO1999045514A1 (en) | 1998-03-03 | 1999-09-10 | Tracking Technologies, Inc. | Identifiable marking compositions and methods |
US5956172A (en) | 1995-05-08 | 1999-09-21 | 3D Technology Laboratories, Inc. | System and method using layered structure for three-dimensional display of information based on two-photon upconversion |
US5977436A (en) | 1997-04-09 | 1999-11-02 | Rhone Poulenc Agrochimie | Oleosin 5' regulatory region for the modification of plant seed lipid composition |
WO1999059011A1 (en) | 1998-05-13 | 1999-11-18 | Spectra Science Corporation | Micro-lasing beads and structures, and associated methods |
US5989823A (en) | 1998-09-18 | 1999-11-23 | Nexstar Pharmaceuticals, Inc. | Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction |
US6013789A (en) | 1998-02-20 | 2000-01-11 | Beckman Coulter, Inc. | Covalent attachment of biomolecules to derivatized polypropylene supports |
US6030657A (en) | 1994-11-01 | 2000-02-29 | Dna Technologies, Inc. | Labeling technique for countering product diversion and product counterfeiting |
US6033880A (en) | 1993-07-28 | 2000-03-07 | The Perkin-Elmer Corporation | Nucleic acid amplification reaction apparatus and method |
US6057370A (en) | 1996-05-30 | 2000-05-02 | Weiland; Robert Timothy | Enhancement of insecticides activity on Bt cotton |
JP2000250812A (en) | 1999-03-01 | 2000-09-14 | Internatl Business Mach Corp <Ibm> | Memory cache system and managing method therefor |
WO2000055609A2 (en) | 1999-03-16 | 2000-09-21 | Cryovac, Inc. | Authentication system and methodology |
US6127120A (en) | 1995-07-25 | 2000-10-03 | University Of Strathclyde | Detection of nucleic acids and nucleic acid units |
US6132996A (en) | 1996-06-17 | 2000-10-17 | The Board Of Trustees Of The Leland Stanford Junior University | Thermocycling apparatus and method |
WO2000061799A2 (en) | 1999-04-13 | 2000-10-19 | Minton, Treharne & Davies Limited | Methods of marking materials |
US6140075A (en) | 1994-07-25 | 2000-10-31 | Monsanto Company | Method for producing antibodies and protein toxins in plant cells |
EP1063286A1 (en) | 1998-02-09 | 2000-12-27 | Toyo Kohan Co., Ltd | Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna |
US6169174B1 (en) | 1996-09-20 | 2001-01-02 | Nisshinbo Industries, Inc. | Cotton plant gene |
JP2001034533A (en) | 1999-07-21 | 2001-02-09 | Nec Kofu Ltd | Cache coherency controller, secondary cache memory, central processor, multiprocessing system, processor node, and cache coherency control method |
WO2001025002A1 (en) | 1999-10-01 | 2001-04-12 | Surromed,Inc. | Colloidal rod particles as nanobar codes |
WO2001036676A2 (en) | 1999-11-19 | 2001-05-25 | Crime Solutions Limited | Security system |
RU2170084C1 (en) | 2000-02-28 | 2001-07-10 | Родионов Сергей Юрьевич | Method of dna tablet making |
US6261809B1 (en) | 1997-09-05 | 2001-07-17 | November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin | Method for marking solid, liquid or gaseous substances |
US6287768B1 (en) | 1998-01-07 | 2001-09-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6312911B1 (en) | 1999-05-06 | 2001-11-06 | Frank Carter Bancroft | DNA-based steganography |
US20010039018A1 (en) | 1999-05-12 | 2001-11-08 | Beckman Coulter, Inc. | Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
US6326489B1 (en) | 1997-08-05 | 2001-12-04 | Howard Hughes Medical Institute | Surface-bound, bimolecular, double-stranded DNA arrays |
WO2001099063A1 (en) | 2000-06-21 | 2001-12-27 | James Leigh Zorab | Remote authentication system |
US6342359B1 (en) | 1999-10-01 | 2002-01-29 | Lg Electronics Inc. | Method for detecting nucleic acids, detector for nucleic acids and method for producing the same |
US6361944B1 (en) | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US20020048822A1 (en) | 1999-09-23 | 2002-04-25 | Rittenburg James H. | Marking of products with electroactive compounds |
US6379897B1 (en) | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
US20020051969A1 (en) | 1995-02-20 | 2002-05-02 | Masaaki Goto | Novel proteins and methods for producing the proteins |
US20020056147A1 (en) | 2000-07-28 | 2002-05-09 | Dau Peter C. | Transgenic identification markers |
US20020064639A1 (en) | 2000-09-29 | 2002-05-30 | Rearick William A. | Cellulosic substrates with reduced absorbent capacity having the capability to wick liquids |
US6399397B1 (en) | 1992-09-14 | 2002-06-04 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
US20020080994A1 (en) | 2000-12-21 | 2002-06-27 | Neil Lofgren | Digitally watermaking holograms for use with smart cards |
WO2002057548A1 (en) | 2001-01-22 | 2002-07-25 | Arjo Wiggins Security Sas | Paper comprising bodies which comprise at least one biochemical marker |
EP1231470A1 (en) | 1999-11-04 | 2002-08-14 | Center for Advanced Science and Technology Incubation, Ltd. | Method for immobilizing substances |
US20020119485A1 (en) | 1999-12-01 | 2002-08-29 | Christopher Morgan | Luminescence assays |
EP1237327A2 (en) | 2001-03-01 | 2002-09-04 | NTT Data Technology Corporation | Method and system for individual authentication and digital signature utilizing article having DNA based ID information mark |
US20020128234A1 (en) | 1999-04-28 | 2002-09-12 | Hubbell Jeffrey A. | Multifunctional polymeric surface coatings in analytic and sensor devices |
US20020137893A1 (en) | 1996-11-15 | 2002-09-26 | Burton Louis E. | Purification of NGF |
US20020155490A1 (en) | 2001-04-18 | 2002-10-24 | Skinner Nigel G. | Particle based assay system |
WO2002084617A1 (en) | 2001-04-10 | 2002-10-24 | Philip Noel Leonard | Electronic systems incorporated into textile threads or fibres |
US20020160360A1 (en) | 1999-11-15 | 2002-10-31 | Alex Chenchik | Long oligonucleotide arrays |
US20020167161A1 (en) | 2001-03-15 | 2002-11-14 | Butland Charles L. | Surface labelled object and method thereof |
US20020187263A1 (en) | 2001-04-09 | 2002-12-12 | Jue-Jei Sheu | Method of utilizing ribonucleic acid as markers for product anti-counterfeit labeling and verification |
US20030000225A1 (en) | 2001-06-07 | 2003-01-02 | Sysmex Corporation | Liquid container and an analyzer equipped therewith |
US20030017551A1 (en) | 2001-04-24 | 2003-01-23 | 3M Innovative Properties Company | Biological sample processing methods and compositions that include surfactants |
US20030035917A1 (en) | 1999-06-11 | 2003-02-20 | Sydney Hyman | Image making medium |
WO2003016558A1 (en) | 2001-08-16 | 2003-02-27 | Corbett Research Pty Ltd | Continuous flow thermal device |
US6537747B1 (en) | 1998-02-03 | 2003-03-25 | Lucent Technologies Inc. | Data transmission using DNA oligomers |
US6537752B1 (en) | 1997-12-08 | 2003-03-25 | Thomas W. Astle | Temperature control system for polymerase chain reaction |
US20030064507A1 (en) | 2001-07-26 | 2003-04-03 | Sean Gallagher | System and methods for mixing within a microfluidic device |
WO2003030129A2 (en) | 2001-09-27 | 2003-04-10 | Ucb, S.A. | Labelled articles and uses thereof |
WO2003038000A1 (en) | 2001-11-02 | 2003-05-08 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Marking solution for counterfeit-resistant identification of a valuable object, marking produced by the marking solution and method for marking a valuable object |
US20030096273A1 (en) | 2001-07-31 | 2003-05-22 | Claude Gagna | Methods for immobilizing molecules to a solid phase and uses thereof |
US6576422B1 (en) | 2000-10-17 | 2003-06-10 | Rohm And Haas Company | Method for identifying products employing gene expression |
US6608228B1 (en) | 1997-11-07 | 2003-08-19 | California Institute Of Technology | Two-photon or higher-order absorbing optical materials for generation of reactive species |
US6613560B1 (en) | 1994-10-19 | 2003-09-02 | Agilent Technologies, Inc. | PCR microreactor for amplifying DNA using microquantities of sample fluid |
WO2003080931A1 (en) | 2002-03-22 | 2003-10-02 | Trace Tag International Ltd | A marking apparatus for nucleic acid marking of items |
US6632653B1 (en) | 1997-12-08 | 2003-10-14 | Thomas W. Astle | Continuous polymerase chain reaction apparatus with multiple temperature stations |
US20030203387A1 (en) | 2002-04-23 | 2003-10-30 | Olivier Pelletier | DNA authentication |
US20030207331A1 (en) | 2000-07-11 | 2003-11-06 | Sri International | Encoding methods using up-converting phosphors for high-throughput screening of catalysts |
US6686149B1 (en) | 1987-06-10 | 2004-02-03 | Institut Pasteur | Methods for obtaining nucleotide sequences coding for polypeptides specifically active for larvae of S. littoralis |
US6703228B1 (en) | 1998-09-25 | 2004-03-09 | Massachusetts Institute Of Technology | Methods and products related to genotyping and DNA analysis |
US20040050701A1 (en) * | 2002-09-13 | 2004-03-18 | Mcentee John Francis | Electrostatically guiding ionized droplets in chemical array fabrication |
US6709692B2 (en) | 2000-10-10 | 2004-03-23 | Genset S.A. | Surface absorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces |
WO2004025562A1 (en) | 2002-09-12 | 2004-03-25 | Cyvera Corp. | Method and apparatus for labelling using diffraction grating-based encoded optical identification elements |
US20040071718A1 (en) | 2002-09-18 | 2004-04-15 | Jaw-Ji Tsai | Local nasal immunotherapy for allergen-induced airway inflammation |
US6743640B2 (en) | 2000-05-08 | 2004-06-01 | Qtl Biosystems Llc | Fluorescent polymer-QTL approach to biosensing |
US20040115796A1 (en) | 1998-05-01 | 2004-06-17 | Burns Ralph E. | Instrument for detecting light emitted by the contents of a reaction receptacle |
CN1508696A (en) | 2002-12-19 | 2004-06-30 | 英特尔公司 | Non-random distribution type conflict solution of cache consistency agreement |
US20040166520A1 (en) | 2003-01-03 | 2004-08-26 | Connolly D. Michael | Identifying items with nucleic acid taggants |
WO2004086323A1 (en) | 2003-03-26 | 2004-10-07 | Janet Elizabeth Williams | Personal safety device |
US20050008762A1 (en) | 2001-04-09 | 2005-01-13 | Jue-Jei Sheu | Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication |
US20050031120A1 (en) | 1999-02-01 | 2005-02-10 | Gideon Samid | Denial featured cryptography |
US20050053968A1 (en) | 2003-03-31 | 2005-03-10 | Council Of Scientific And Industrial Research | Method for storing information in DNA |
US20050059029A1 (en) | 2002-11-22 | 2005-03-17 | The Regents Of The University Of California | Derivatized versions of ligase enzymes for constructing DNA sequences |
US20050059059A1 (en) | 2003-08-06 | 2005-03-17 | Benjamin Liang | Novel nucleic acid based steganography system and application thereof |
US20050089970A1 (en) * | 2000-07-12 | 2005-04-28 | Bradburne James A. | Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
US20050112610A1 (en) | 2003-04-16 | 2005-05-26 | Applied Dna Sciences, Inc. | System and method for marking textiles with nucleic acids |
US20050142565A1 (en) | 2003-12-30 | 2005-06-30 | Agency For Science, Technology And Research | Nucleic acid purification chip |
US20050214532A1 (en) | 2001-05-11 | 2005-09-29 | Hans Kosak | Secueity thread for the forgery-proof making of objects |
WO2005103226A2 (en) | 2004-03-24 | 2005-11-03 | Wisconsin Alumni Research Foundation | Plasma-enhanced functionalization of inorganic oxide surfaces |
US20050260609A1 (en) | 2004-05-24 | 2005-11-24 | Lapidus Stanley N | Methods and devices for sequencing nucleic acids |
US20060017957A1 (en) | 2002-09-24 | 2006-01-26 | Bend Kurzmann Mathias Pieroth | Method and ink sets for marking and authenticating articles |
US20060017959A1 (en) | 2004-07-06 | 2006-01-26 | Downer Raymond J | Document classification and authentication |
US6995256B1 (en) | 2000-08-01 | 2006-02-07 | Temasek Life Sciences Laboratory Limited | Isolation and characterization of a fiber-specific actin promoter from cotton |
US7014113B1 (en) | 2002-08-19 | 2006-03-21 | The Code Corporation | Versatile graphical code reader for reading different types of graphical codes |
US7015030B1 (en) | 1999-07-28 | 2006-03-21 | Genset S.A. | Microfluidic devices and uses thereof in biochemical processes |
US7031927B1 (en) | 2000-04-12 | 2006-04-18 | Strategic Weather Services | System, method, and computer program product for weather and terrestrial vegetation-based water renovation and management forecasting |
US20060117465A1 (en) | 2004-12-03 | 2006-06-08 | Willows Keith S | Number/bib holder |
US7060874B2 (en) | 2002-05-17 | 2006-06-13 | The Regents Of The University Of California | Bioengineering cotton fiber properties |
US20060199196A1 (en) | 2004-11-05 | 2006-09-07 | Invitrogen Corporation | Compositions and methods for using radio frequency identifiers in biological sciences |
US7112616B2 (en) | 2003-03-25 | 2006-09-26 | Fuji Photo Film Co., Ltd. | Two-photon absorbing polymerizable composition and polymerization process thereof |
WO2006109014A1 (en) | 2005-04-15 | 2006-10-19 | University Of Durham | Thiol functionalised coatings and method for producing the same |
US7133726B1 (en) | 1997-03-28 | 2006-11-07 | Applera Corporation | Thermal cycler for PCR |
US20060286569A1 (en) | 2005-03-10 | 2006-12-21 | Bar-Or Yuval A | Method, apparatus, and system for authentication using labels containing nucleotide sequences |
US7160996B1 (en) | 1999-06-09 | 2007-01-09 | Bioresearch Technologies, Inc. | Fluorescence energy transfer probes with stabilized conformations |
US20070012784A1 (en) | 2005-06-20 | 2007-01-18 | Mercolino Thomas J | Product authentication |
US20070026239A1 (en) | 2003-08-26 | 2007-02-01 | Csem Centre Suisse D-Electronique Et De Microtechique Sa | Functionalization of yarn and textile products |
US20070048761A1 (en) | 2005-05-20 | 2007-03-01 | Applied Dna Sciences, Inc. | System and method for authenticating multiple components associated with a particular product |
US20070072197A1 (en) | 2005-09-28 | 2007-03-29 | Rayms-Keller Alfredo N | Microtags for detection and identification of materials |
US20070117119A1 (en) | 1999-03-05 | 2007-05-24 | Mitsubishi Rayon Co., Ltd. | Carriers having biological substance |
US7223906B2 (en) | 2001-02-14 | 2007-05-29 | Natural Genes, Inc. | B-2-1ctHgg cotton displaying genetically-controlled naturally-occurring herbicide resistance, method for transfer, and method of use |
US20070121937A1 (en) | 2003-06-26 | 2007-05-31 | Kochevar Peter D | Site-specific access management |
WO2007078833A2 (en) | 2005-12-16 | 2007-07-12 | The Curators Of The University Of Missouri | Reusable pcr amplification system and method |
US7250195B1 (en) | 2006-02-27 | 2007-07-31 | Ionic Fusion Corporation | Molecular plasma deposition of colloidal materials |
GB2434570A (en) | 2006-01-31 | 2007-08-01 | Alexander Peter Mackay | Applying DNA as an item label |
EP1847316A1 (en) | 2006-04-19 | 2007-10-24 | Eppendorf Array Technologies SA (EAT) | Method for stabilizing functional groups on a surface of a polymer used as solid support for making microarrays |
US20070254292A1 (en) | 2004-08-20 | 2007-11-01 | Asahi Kasei Kabushiki Kaisha | Method for Trapping Nucleic Acids Using Divalent Metal Ions |
WO2008007060A1 (en) | 2006-07-08 | 2008-01-17 | Redweb Security (Uk) Limited | Marking material |
US20080045288A1 (en) | 2006-08-17 | 2008-02-21 | Waterleaf Limited | Method and System for Indicating a Jackpot Payout Expectancy for a Game |
US20080081357A1 (en) | 2006-09-29 | 2008-04-03 | Samsung Electronics Co., Ltd. | Method and apparatus for isolating nucleic acids from a cell using carbon nanotubes and silica beads |
US20080153135A1 (en) | 2006-12-20 | 2008-06-26 | Liu Timothy Z | Methods and apparatus for conducting amplification reactions on high density hydrophilic patterned microplates |
US20080149713A1 (en) | 2003-08-13 | 2008-06-26 | Brundage Trent J | Detecting Media Areas Likely of Hosting Watermarks |
US20080216255A1 (en) | 2005-09-17 | 2008-09-11 | Robert Lee Poovey | Textile Marker Application Method and Textiles Produced therefrom |
US20080293052A1 (en) | 2003-04-16 | 2008-11-27 | Ming-Hwa Liang | System and method for authenticating sports identification goods |
US20080299559A1 (en) | 2003-04-16 | 2008-12-04 | Thomas Kwok | Methods for authenticating articles with optical reporters |
WO2008154931A1 (en) | 2007-06-18 | 2008-12-24 | Danmarks Tekniske Universitet (Technical University Of Denmark) | Adsorbent beads suitable for use in separation of biological molecules |
US20090042191A1 (en) | 2003-04-16 | 2009-02-12 | Hayward James A | System and method for secure document printing and detection |
US20090057147A1 (en) | 1999-04-21 | 2009-03-05 | Clinical Micro Sensors, Inc. | Devices and methods for biochip multiplexing |
US20090069199A1 (en) | 2007-07-16 | 2009-03-12 | Albrecht Brandenburg | Method and device for optical detection of substances in a liquid or gaseous medium |
US20090075261A1 (en) | 2003-04-16 | 2009-03-19 | Hayward James A | System and method for authenticating tablets |
JP2009517250A (en) | 2005-11-30 | 2009-04-30 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Laser transfer of security function |
US20090136163A1 (en) | 2007-08-02 | 2009-05-28 | George Scott Kerr | Bag and article of manufacture |
US20090222912A1 (en) | 2008-02-29 | 2009-09-03 | Boschin Luigi | Identification device and authentication method through such a device |
US20090220789A1 (en) | 2006-01-27 | 2009-09-03 | The University Of North Carolina At Chapel Hill | Taggants and methods and systems for fabricating same |
US20090253127A1 (en) | 2004-11-17 | 2009-10-08 | Forensink Corporation Inc. | Compositions for Marking Objects with DNA and Methods for Marking and Linking an Object to its Owner |
US20090286250A1 (en) | 2006-05-19 | 2009-11-19 | James Arthur Hayward | Incorporating soluble security markers into cyanoacrylate solutions |
US20090313740A1 (en) | 2001-11-07 | 2009-12-24 | Santos Luisa Demorais | Camouflage U.S. Marine Corps combat utility uniform: pattern, fabric, and design |
US20100050344A1 (en) | 2008-08-28 | 2010-03-04 | Dirty Laundry, Llc | Laundry stain and soil pretreatment sheet |
US20100075407A1 (en) | 2008-09-23 | 2010-03-25 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
US20100099080A1 (en) | 2002-05-01 | 2010-04-22 | President And Fellows Of Harvard College | Nucleic acid memory device |
US7732492B2 (en) | 2003-08-08 | 2010-06-08 | Ajinomoto Co., Inc. | Nateglinide-containing preparation |
US20100149531A1 (en) | 2008-12-13 | 2010-06-17 | Allegro Asia Technology (Hk) Ltd. | Apparatus and method for object authentication using taggant material |
WO2010075858A2 (en) | 2009-01-05 | 2010-07-08 | Synthesechemie Dr. Penth Gmbh | Measuring machine and method for detecting the content of oil, hydrocarbons, and oxidizable gases in air or compressed air |
US20100240101A1 (en) | 2009-03-19 | 2010-09-23 | Massachusetts Institute Of Technology | Parallel Proximity Ligation Event Analysis |
US20100250616A1 (en) | 2009-03-24 | 2010-09-30 | Kim Richard C | Memorabilia registry system |
US20100258743A1 (en) | 2009-04-13 | 2010-10-14 | Src, Inc. | Location Analysis Using Nucleic Acid-Labeled Tags |
US20100285490A1 (en) | 2006-12-29 | 2010-11-11 | Invitrogen Corporation | Detection apparatus |
US20100285985A1 (en) | 2003-04-15 | 2010-11-11 | Applied Dna Sciences, Inc. | Methods and Systems for the Generation of Plurality of Security Markers and the Detection Therof |
US20100285447A1 (en) | 2009-05-07 | 2010-11-11 | Biomerieux, Inc. | Methods for Antimicrobial Resistance Determination |
US20100307120A1 (en) | 2009-06-05 | 2010-12-09 | Stover Jimmy R | Harvester with heated duct |
US20110014133A1 (en) * | 2008-02-14 | 2011-01-20 | Grunstein Michael M | Compositions and Methods to Treat Asthma |
US20110054938A1 (en) | 2009-08-28 | 2011-03-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Devices and methods for detecting an analyte in salivary fluid |
US20110165569A1 (en) | 2010-01-07 | 2011-07-07 | Jeansee Llc | Combinatorial dna taggants and methods of preparation and use thereof |
US20110229881A1 (en) | 2008-09-11 | 2011-09-22 | Nagahama Bio-Laboratory Incorporated | Dna-containing ink composition |
US20110250594A1 (en) | 2008-11-12 | 2011-10-13 | Ming-Hwa Liang | Methods for genetic analysis of textiles made of gossypium barbadense and gossypium hirsutum cotton |
US20110263688A1 (en) | 2008-04-09 | 2011-10-27 | Purdue Research Foundation | Coferons and methods of making and using them |
EP2428925A1 (en) | 2010-08-27 | 2012-03-14 | JT International | Product authentication method |
EP2444546A1 (en) | 2010-10-20 | 2012-04-25 | Centro Tessile Cotoniero e Abbigliamento S.p.A. | Method for biomarking textile materials |
EP2444136A1 (en) | 2010-10-22 | 2012-04-25 | Bandit NV | A fog generator comprising a fog generating marker fluid |
US20120115154A1 (en) | 2004-12-23 | 2012-05-10 | Greg Hampikian | Reference markers for biological samples |
WO2012076021A1 (en) | 2010-12-10 | 2012-06-14 | Nkt Photonics A/S | An acousto-optical tunable filter (aotf) for a broad band source for fluorescence measurement system |
US8278807B2 (en) | 2006-10-17 | 2012-10-02 | Renault S.A.S. | Radiofrequency plasma generation device |
US20120264742A1 (en) | 2009-11-12 | 2012-10-18 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition for external use |
US20130040150A1 (en) | 2011-08-10 | 2013-02-14 | The Johns Hopkins University | Nanoparticle Taggants for Explosive Precursors |
US20130046994A1 (en) | 2011-08-17 | 2013-02-21 | Harry C. Shaw | Integrated genomic and proteomic security protocol |
US20130048731A1 (en) | 2011-08-25 | 2013-02-28 | International Business Machines Corporation | System for recovering a barcode |
WO2013052924A1 (en) | 2011-10-06 | 2013-04-11 | AI Cure Technologies, Inc. | Method and apparatus for fractal identification |
US20130109596A1 (en) | 2011-09-26 | 2013-05-02 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
US20130234043A1 (en) | 2012-03-09 | 2013-09-12 | United States Postal Service | Method and system for item authentication and customization |
US20130274129A1 (en) | 2012-04-04 | 2013-10-17 | Geneart Ag | Tal-effector assembly platform, customized services, kits and assays |
WO2013154943A1 (en) | 2012-04-09 | 2013-10-17 | Applied Dna Sciences, Inc. | Plasma treatment for dna binding |
WO2013170009A1 (en) | 2012-05-09 | 2013-11-14 | Applied Dna Sciences, Inc. | Verification of physical encryption taggants uning digital representatives and authentications thereof |
US20140099643A1 (en) | 2012-10-10 | 2014-04-10 | Applied Dna Sciences, Inc. | Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings |
US20140106357A1 (en) | 2012-10-16 | 2014-04-17 | Applied Dna Sciences, Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
US20140224673A1 (en) | 2013-02-08 | 2014-08-14 | Board Of Trustees Of Michigan State University | Nanoparticle-serialized oligonucleotide methods, compositions, and articles |
US20140256881A1 (en) | 2013-03-07 | 2014-09-11 | Applied Dna Sciences, Inc. | Alkaline activation for immobilization of dna taggants |
US20140272097A1 (en) | 2013-03-12 | 2014-09-18 | Applied Dna Sciences, Inc. | Dna marking of previously undistinguished items for traceability |
US20150018538A1 (en) | 2013-03-07 | 2015-01-15 | Applied Dna Sciences, Inc. | Method and device for marking articles |
US20150030545A1 (en) | 2012-03-26 | 2015-01-29 | Eth Zurich | Molecular code systems |
US20150107475A1 (en) | 2012-10-10 | 2015-04-23 | Apdn (B.V.I.) Inc. | Dna marking of previously undistinguished items for traceability |
US20150125949A1 (en) | 2007-11-30 | 2015-05-07 | Geneart Ag | Steganographic embedding of information in coding genes |
US20150133319A1 (en) | 2012-02-27 | 2015-05-14 | Cellular Research, Inc. | Compositions and kits for molecular counting |
US20160168781A1 (en) | 2014-12-16 | 2016-06-16 | Apdn (B.V.I.) Inc. | Method and device for marking fibrous materials |
-
2014
- 2014-12-15 US US14/570,242 patent/US10741034B2/en active Active
Patent Citations (250)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2428925A (en) | 1944-01-29 | 1947-10-14 | Honeywell Regulator Co | Gyroscope construction |
US4183989A (en) | 1976-12-07 | 1980-01-15 | Portals Limited | Security papers |
US4183989B1 (en) | 1976-12-07 | 1990-05-08 | Portals Ltd | |
US4278557A (en) | 1980-04-15 | 1981-07-14 | The United States Of America As Represented By The Secretary Of The Air Force | Solvent mixture for dissolving and removing epoxy resinous compounds |
US4454171A (en) | 1980-12-08 | 1984-06-12 | Samcoe Holding Corporation | Method for wet processing, drying and moisture conditioning tubular knitted fabric |
EP0140333A2 (en) | 1983-10-28 | 1985-05-08 | Alcatel N.V. | Sound reproducing system |
US4849208A (en) | 1984-01-30 | 1989-07-18 | Enzo Biochem, Inc. | Detectable molecules, method of preparation and use |
US4548955A (en) | 1985-02-25 | 1985-10-22 | Sogo Pharmaceutical Company Limited | Nylon capsule responding to pH |
US4739044A (en) | 1985-06-13 | 1988-04-19 | Amgen | Method for derivitization of polynucleotides |
US4757141A (en) | 1985-08-26 | 1988-07-12 | Applied Biosystems, Incorporated | Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof |
US4683195B1 (en) | 1986-01-30 | 1990-11-27 | Cetus Corp | |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
JPS63503242A (en) | 1986-04-09 | 1988-11-24 | バイオタル・リミテツド | A sign for an item whose authenticity you want to prove |
WO1987006383A1 (en) | 1986-04-09 | 1987-10-22 | Biotal Limited | Labelling articles it is wished to authenticate |
US5599578A (en) | 1986-04-30 | 1997-02-04 | Butland; Charles L. | Technique for labeling an object for its identification and/or verification |
US5151507A (en) | 1986-07-02 | 1992-09-29 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
US5047519A (en) | 1986-07-02 | 1991-09-10 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4861620A (en) | 1986-11-14 | 1989-08-29 | Mitsubishi Denki Kabushiki Kaisha | Method of laser marking |
US6686149B1 (en) | 1987-06-10 | 2004-02-03 | Institut Pasteur | Methods for obtaining nucleotide sequences coding for polypeptides specifically active for larvae of S. littoralis |
US5132242A (en) | 1987-07-15 | 1992-07-21 | Cheung Sau W | Fluorescent microspheres and methods of using them |
US5429952A (en) | 1988-02-02 | 1995-07-04 | Biocode, Inc. | Marking of products to establish identity and source |
US5776713A (en) | 1988-02-02 | 1998-07-07 | Biocode Ltd. | Marking of products to establish identity and source |
US5075216A (en) | 1988-09-23 | 1991-12-24 | Cetus Corporation | Methods for dna sequencing with thermus aquaticus dna polymerase |
WO1990014441A1 (en) | 1989-05-22 | 1990-11-29 | Cetus Corporation | Methods for tagging and tracing materials with nucleic acids |
EP0477220B1 (en) | 1989-05-22 | 1996-09-04 | F. Hoffmann-La Roche Ag | Methods for tagging and tracing materials with nucleic acids |
US5451505A (en) | 1989-05-22 | 1995-09-19 | Hoffmann-La Roche Inc. | Methods for tagging and tracing materials with nucleic acids |
US5139812A (en) | 1989-07-07 | 1992-08-18 | Bioprobe Systems | Method and apparatus for high security crypto-marking for protecting valuable objects |
US5089691A (en) | 1989-07-11 | 1992-02-18 | Brother Kogyo Kabushiki Kaisha | Image recording apparatus having bar code reader for reading bar code attached to leading end of microcapsule sheet |
US5176203A (en) | 1989-08-05 | 1993-01-05 | Societe De Conseils De Recherches Et D'applications Scientifiques | Apparatus for repeated automatic execution of a thermal cycle for treatment of samples |
US5156765A (en) | 1990-05-15 | 1992-10-20 | Fox Valley Systems, Inc. | Aerosol foam marking compositions |
WO1992004469A2 (en) | 1990-09-06 | 1992-03-19 | Imperial Chemical Industries Plc | Nucleic acid detection method using particle agglutination |
US5270183A (en) | 1991-02-08 | 1993-12-14 | Beckman Research Institute Of The City Of Hope | Device and method for the automated cycling of solutions between two or more temperatures |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5643728A (en) | 1992-08-26 | 1997-07-01 | Slater; James Howard | Method of marking a liquid |
US6399397B1 (en) | 1992-09-14 | 2002-06-04 | Sri International | Up-converting reporters for biological and other assays using laser excitation techniques |
JPH06187239A (en) | 1992-12-18 | 1994-07-08 | Nippon Telegr & Teleph Corp <Ntt> | Data coincidence control system for multi-layered cache memory |
EP0623658A2 (en) | 1993-05-05 | 1994-11-09 | Imperial Chemical Industries Plc | Indelible ink formation |
US5602381A (en) | 1993-05-19 | 1997-02-11 | Nhk Spring Co., Ltd. | Objects to be checked for authenticity, and method and apparatus for checking whether or not objects are authentic |
US5763176A (en) | 1993-07-12 | 1998-06-09 | Slater; James Howard | Methods and devices for marking a solid and subsequently detecting the markings |
WO1995002702A1 (en) | 1993-07-12 | 1995-01-26 | James Howard Slater | A security device using an ultrasensitive microtrace for protecting materials, articles and items |
US6033880A (en) | 1993-07-28 | 2000-03-07 | The Perkin-Elmer Corporation | Nucleic acid amplification reaction apparatus and method |
WO1995006249A1 (en) | 1993-08-20 | 1995-03-02 | Biocode, Inc. | Marking of products to establish identity and source |
US5595871A (en) | 1993-08-25 | 1997-01-21 | University Of Scranton | Detection and prevention of mycoplasma hominis infection |
US5415839A (en) | 1993-10-21 | 1995-05-16 | Abbott Laboratories | Apparatus and method for amplifying and detecting target nucleic acids |
US6140075A (en) | 1994-07-25 | 2000-10-31 | Monsanto Company | Method for producing antibodies and protein toxins in plant cells |
US5508197A (en) | 1994-07-25 | 1996-04-16 | The Regents, University Of California | High-speed thermal cycling system and method of use |
US5498283A (en) | 1994-08-23 | 1996-03-12 | Scitex Digital Printing, Inc. | Waterfast security inks |
US6613560B1 (en) | 1994-10-19 | 2003-09-02 | Agilent Technologies, Inc. | PCR microreactor for amplifying DNA using microquantities of sample fluid |
US6030657A (en) | 1994-11-01 | 2000-02-29 | Dna Technologies, Inc. | Labeling technique for countering product diversion and product counterfeiting |
US20020051969A1 (en) | 1995-02-20 | 2002-05-02 | Masaaki Goto | Novel proteins and methods for producing the proteins |
US5956172A (en) | 1995-05-08 | 1999-09-21 | 3D Technology Laboratories, Inc. | System and method using layered structure for three-dimensional display of information based on two-photon upconversion |
WO1997004392A1 (en) | 1995-07-19 | 1997-02-06 | International Business Machines Corporation | Shared cache memory device |
US6127120A (en) | 1995-07-25 | 2000-10-03 | University Of Strathclyde | Detection of nucleic acids and nucleic acid units |
US5912257A (en) | 1995-09-06 | 1999-06-15 | The Research Foundation Of State University Of New York | Two-photon upconverting dyes and applications |
US5736314A (en) | 1995-11-16 | 1998-04-07 | Microfab Technologies, Inc. | Inline thermo-cycler |
RU2084535C1 (en) | 1995-11-29 | 1997-07-20 | Галина Филиповна Сиволобова | Method of marking and identification of valuable documents |
US6057370A (en) | 1996-05-30 | 2000-05-02 | Weiland; Robert Timothy | Enhancement of insecticides activity on Bt cotton |
WO1997045539A1 (en) | 1996-05-31 | 1997-12-04 | Mikael Kubista | Probe for analysis of nucleic acids |
US6132996A (en) | 1996-06-17 | 2000-10-17 | The Board Of Trustees Of The Leland Stanford Junior University | Thermocycling apparatus and method |
US5866336A (en) | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
US6361944B1 (en) | 1996-07-29 | 2002-03-26 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
WO1998006084A1 (en) | 1996-08-02 | 1998-02-12 | Beijing Sanzhu Xinda Biological Probe Co., Ltd. | A method of nucleic acid code analystic technique used in falseproof label |
US6169174B1 (en) | 1996-09-20 | 2001-01-02 | Nisshinbo Industries, Inc. | Cotton plant gene |
WO1998016313A1 (en) | 1996-10-12 | 1998-04-23 | Central Research Laboratories Limited | Heating apparatus |
EP0840350A2 (en) | 1996-11-04 | 1998-05-06 | Applied Materials, Inc. | Plasma apparatus and process with filtering of plasma sheath-generated harmonics |
US8597549B2 (en) | 1996-11-12 | 2013-12-03 | The California Institute Of Technology | Two-photon or higher-order absorbing optical materials for generation of reactive species |
GB2319337A (en) | 1996-11-12 | 1998-05-20 | Probe Fx Patents Limited | Composition for applying to goods as tracer or identifier |
US20020137893A1 (en) | 1996-11-15 | 2002-09-26 | Burton Louis E. | Purification of NGF |
US5942444A (en) | 1997-01-27 | 1999-08-24 | Biocode, Inc. | Marking of products to establish identity, source and fate |
US7133726B1 (en) | 1997-03-28 | 2006-11-07 | Applera Corporation | Thermal cycler for PCR |
US5977436A (en) | 1997-04-09 | 1999-11-02 | Rhone Poulenc Agrochimie | Oleosin 5' regulatory region for the modification of plant seed lipid composition |
US6326489B1 (en) | 1997-08-05 | 2001-12-04 | Howard Hughes Medical Institute | Surface-bound, bimolecular, double-stranded DNA arrays |
US6261809B1 (en) | 1997-09-05 | 2001-07-17 | November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin | Method for marking solid, liquid or gaseous substances |
US6608228B1 (en) | 1997-11-07 | 2003-08-19 | California Institute Of Technology | Two-photon or higher-order absorbing optical materials for generation of reactive species |
US6632653B1 (en) | 1997-12-08 | 2003-10-14 | Thomas W. Astle | Continuous polymerase chain reaction apparatus with multiple temperature stations |
US6537752B1 (en) | 1997-12-08 | 2003-03-25 | Thomas W. Astle | Temperature control system for polymerase chain reaction |
US6287768B1 (en) | 1998-01-07 | 2001-09-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
US6537747B1 (en) | 1998-02-03 | 2003-03-25 | Lucent Technologies Inc. | Data transmission using DNA oligomers |
EP1063286A1 (en) | 1998-02-09 | 2000-12-27 | Toyo Kohan Co., Ltd | Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna |
US6013789A (en) | 1998-02-20 | 2000-01-11 | Beckman Coulter, Inc. | Covalent attachment of biomolecules to derivatized polypropylene supports |
WO1999045514A1 (en) | 1998-03-03 | 1999-09-10 | Tracking Technologies, Inc. | Identifiable marking compositions and methods |
US20040115796A1 (en) | 1998-05-01 | 2004-06-17 | Burns Ralph E. | Instrument for detecting light emitted by the contents of a reaction receptacle |
US20030162296A1 (en) | 1998-05-13 | 2003-08-28 | Lawandy Nabil M. | Micro-lasing beads and structures for combinatorial chemistry and other applications, and techniques for fabricating the structures and for detecting information encoded by the structures |
US20030142713A1 (en) | 1998-05-13 | 2003-07-31 | Lawandy Nabil M. | Micro-lasing beads and structures for combinatorial chemistry and other applications, and techniques for fabricating the structures and for detecting information encoded by the structures |
US20030142704A1 (en) | 1998-05-13 | 2003-07-31 | Lawandy Nabil M. | Micro-lasing beads and structures for combinatorial chemistry and other applications, and techniques for fabricating the structures and for detecting information encoded by the structures |
WO1999059011A1 (en) | 1998-05-13 | 1999-11-18 | Spectra Science Corporation | Micro-lasing beads and structures, and associated methods |
US5989823A (en) | 1998-09-18 | 1999-11-23 | Nexstar Pharmaceuticals, Inc. | Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction |
US6703228B1 (en) | 1998-09-25 | 2004-03-09 | Massachusetts Institute Of Technology | Methods and products related to genotyping and DNA analysis |
US20050031120A1 (en) | 1999-02-01 | 2005-02-10 | Gideon Samid | Denial featured cryptography |
JP2000250812A (en) | 1999-03-01 | 2000-09-14 | Internatl Business Mach Corp <Ibm> | Memory cache system and managing method therefor |
US20070117119A1 (en) | 1999-03-05 | 2007-05-24 | Mitsubishi Rayon Co., Ltd. | Carriers having biological substance |
WO2000055609A2 (en) | 1999-03-16 | 2000-09-21 | Cryovac, Inc. | Authentication system and methodology |
WO2000061799A2 (en) | 1999-04-13 | 2000-10-19 | Minton, Treharne & Davies Limited | Methods of marking materials |
US20090057147A1 (en) | 1999-04-21 | 2009-03-05 | Clinical Micro Sensors, Inc. | Devices and methods for biochip multiplexing |
US20020128234A1 (en) | 1999-04-28 | 2002-09-12 | Hubbell Jeffrey A. | Multifunctional polymeric surface coatings in analytic and sensor devices |
US6312911B1 (en) | 1999-05-06 | 2001-11-06 | Frank Carter Bancroft | DNA-based steganography |
US20010039018A1 (en) | 1999-05-12 | 2001-11-08 | Beckman Coulter, Inc. | Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
US7160996B1 (en) | 1999-06-09 | 2007-01-09 | Bioresearch Technologies, Inc. | Fluorescence energy transfer probes with stabilized conformations |
US20030035917A1 (en) | 1999-06-11 | 2003-02-20 | Sydney Hyman | Image making medium |
JP2001034533A (en) | 1999-07-21 | 2001-02-09 | Nec Kofu Ltd | Cache coherency controller, secondary cache memory, central processor, multiprocessing system, processor node, and cache coherency control method |
US7015030B1 (en) | 1999-07-28 | 2006-03-21 | Genset S.A. | Microfluidic devices and uses thereof in biochemical processes |
US20020048822A1 (en) | 1999-09-23 | 2002-04-25 | Rittenburg James H. | Marking of products with electroactive compounds |
WO2001025002A1 (en) | 1999-10-01 | 2001-04-12 | Surromed,Inc. | Colloidal rod particles as nanobar codes |
US6342359B1 (en) | 1999-10-01 | 2002-01-29 | Lg Electronics Inc. | Method for detecting nucleic acids, detector for nucleic acids and method for producing the same |
EP1231470A1 (en) | 1999-11-04 | 2002-08-14 | Center for Advanced Science and Technology Incubation, Ltd. | Method for immobilizing substances |
US20020160360A1 (en) | 1999-11-15 | 2002-10-31 | Alex Chenchik | Long oligonucleotide arrays |
WO2001036676A2 (en) | 1999-11-19 | 2001-05-25 | Crime Solutions Limited | Security system |
US20020119485A1 (en) | 1999-12-01 | 2002-08-29 | Christopher Morgan | Luminescence assays |
RU2170084C1 (en) | 2000-02-28 | 2001-07-10 | Родионов Сергей Юрьевич | Method of dna tablet making |
US7031927B1 (en) | 2000-04-12 | 2006-04-18 | Strategic Weather Services | System, method, and computer program product for weather and terrestrial vegetation-based water renovation and management forecasting |
US6743640B2 (en) | 2000-05-08 | 2004-06-01 | Qtl Biosystems Llc | Fluorescent polymer-QTL approach to biosensing |
US20030177095A1 (en) | 2000-06-21 | 2003-09-18 | Zorab James Leigh | Remote authentication system |
WO2001099063A1 (en) | 2000-06-21 | 2001-12-27 | James Leigh Zorab | Remote authentication system |
US20030207331A1 (en) | 2000-07-11 | 2003-11-06 | Sri International | Encoding methods using up-converting phosphors for high-throughput screening of catalysts |
US20050089970A1 (en) * | 2000-07-12 | 2005-04-28 | Bradburne James A. | Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
US20020056147A1 (en) | 2000-07-28 | 2002-05-09 | Dau Peter C. | Transgenic identification markers |
US6995256B1 (en) | 2000-08-01 | 2006-02-07 | Temasek Life Sciences Laboratory Limited | Isolation and characterization of a fiber-specific actin promoter from cotton |
US20020064639A1 (en) | 2000-09-29 | 2002-05-30 | Rearick William A. | Cellulosic substrates with reduced absorbent capacity having the capability to wick liquids |
US6709692B2 (en) | 2000-10-10 | 2004-03-23 | Genset S.A. | Surface absorbing polymers and the uses thereof to treat hydrophobic or hydrophilic surfaces |
US6576422B1 (en) | 2000-10-17 | 2003-06-10 | Rohm And Haas Company | Method for identifying products employing gene expression |
US6379897B1 (en) | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
US20020080994A1 (en) | 2000-12-21 | 2002-06-27 | Neil Lofgren | Digitally watermaking holograms for use with smart cards |
US20040063117A1 (en) | 2001-01-22 | 2004-04-01 | Sandrine Rancien | Paper including bodies carrying at least one biochemical marker |
WO2002057548A1 (en) | 2001-01-22 | 2002-07-25 | Arjo Wiggins Security Sas | Paper comprising bodies which comprise at least one biochemical marker |
US7223906B2 (en) | 2001-02-14 | 2007-05-29 | Natural Genes, Inc. | B-2-1ctHgg cotton displaying genetically-controlled naturally-occurring herbicide resistance, method for transfer, and method of use |
EP1237327A2 (en) | 2001-03-01 | 2002-09-04 | NTT Data Technology Corporation | Method and system for individual authentication and digital signature utilizing article having DNA based ID information mark |
US20020129251A1 (en) | 2001-03-01 | 2002-09-12 | Yukio Itakura | Method and system for individual authentication and digital signature utilizing article having DNA based ID information mark |
US20020167161A1 (en) | 2001-03-15 | 2002-11-14 | Butland Charles L. | Surface labelled object and method thereof |
US20020187263A1 (en) | 2001-04-09 | 2002-12-12 | Jue-Jei Sheu | Method of utilizing ribonucleic acid as markers for product anti-counterfeit labeling and verification |
US7115301B2 (en) | 2001-04-09 | 2006-10-03 | Rixflex Holdings Limited | Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication |
US20050008762A1 (en) | 2001-04-09 | 2005-01-13 | Jue-Jei Sheu | Method of marking solid or liquid substances with nucleic acid for anti-counterfeiting and authentication |
WO2002084617A1 (en) | 2001-04-10 | 2002-10-24 | Philip Noel Leonard | Electronic systems incorporated into textile threads or fibres |
US20020155490A1 (en) | 2001-04-18 | 2002-10-24 | Skinner Nigel G. | Particle based assay system |
US20030017551A1 (en) | 2001-04-24 | 2003-01-23 | 3M Innovative Properties Company | Biological sample processing methods and compositions that include surfactants |
US20050214532A1 (en) | 2001-05-11 | 2005-09-29 | Hans Kosak | Secueity thread for the forgery-proof making of objects |
US20030000225A1 (en) | 2001-06-07 | 2003-01-02 | Sysmex Corporation | Liquid container and an analyzer equipped therewith |
US20030064507A1 (en) | 2001-07-26 | 2003-04-03 | Sean Gallagher | System and methods for mixing within a microfluidic device |
US20030096273A1 (en) | 2001-07-31 | 2003-05-22 | Claude Gagna | Methods for immobilizing molecules to a solid phase and uses thereof |
US7709250B2 (en) | 2001-08-16 | 2010-05-04 | Corbett Research Pty Ltd | Continuous flow thermal device |
WO2003016558A1 (en) | 2001-08-16 | 2003-02-27 | Corbett Research Pty Ltd | Continuous flow thermal device |
US20040219287A1 (en) | 2001-09-27 | 2004-11-04 | Christopher Regan | Labelled articles and uses thereof |
WO2003030129A2 (en) | 2001-09-27 | 2003-04-10 | Ucb, S.A. | Labelled articles and uses thereof |
WO2003038000A1 (en) | 2001-11-02 | 2003-05-08 | november Aktiengesellschaft Gesellschaft für Molekulare Medizin | Marking solution for counterfeit-resistant identification of a valuable object, marking produced by the marking solution and method for marking a valuable object |
US20090313740A1 (en) | 2001-11-07 | 2009-12-24 | Santos Luisa Demorais | Camouflage U.S. Marine Corps combat utility uniform: pattern, fabric, and design |
US20060121181A1 (en) | 2002-03-22 | 2006-06-08 | Robert Sleat | Marking apparatus for nucleic acid marking of items |
WO2003080931A1 (en) | 2002-03-22 | 2003-10-02 | Trace Tag International Ltd | A marking apparatus for nucleic acid marking of items |
US20030203387A1 (en) | 2002-04-23 | 2003-10-30 | Olivier Pelletier | DNA authentication |
US20100099080A1 (en) | 2002-05-01 | 2010-04-22 | President And Fellows Of Harvard College | Nucleic acid memory device |
US7060874B2 (en) | 2002-05-17 | 2006-06-13 | The Regents Of The University Of California | Bioengineering cotton fiber properties |
US7014113B1 (en) | 2002-08-19 | 2006-03-21 | The Code Corporation | Versatile graphical code reader for reading different types of graphical codes |
WO2004025562A1 (en) | 2002-09-12 | 2004-03-25 | Cyvera Corp. | Method and apparatus for labelling using diffraction grating-based encoded optical identification elements |
US20040050701A1 (en) * | 2002-09-13 | 2004-03-18 | Mcentee John Francis | Electrostatically guiding ionized droplets in chemical array fabrication |
US20040071718A1 (en) | 2002-09-18 | 2004-04-15 | Jaw-Ji Tsai | Local nasal immunotherapy for allergen-induced airway inflammation |
US20060017957A1 (en) | 2002-09-24 | 2006-01-26 | Bend Kurzmann Mathias Pieroth | Method and ink sets for marking and authenticating articles |
US20050059029A1 (en) | 2002-11-22 | 2005-03-17 | The Regents Of The University Of California | Derivatized versions of ligase enzymes for constructing DNA sequences |
CN1508696A (en) | 2002-12-19 | 2004-06-30 | 英特尔公司 | Non-random distribution type conflict solution of cache consistency agreement |
US20040166520A1 (en) | 2003-01-03 | 2004-08-26 | Connolly D. Michael | Identifying items with nucleic acid taggants |
US7112616B2 (en) | 2003-03-25 | 2006-09-26 | Fuji Photo Film Co., Ltd. | Two-photon absorbing polymerizable composition and polymerization process thereof |
WO2004086323A1 (en) | 2003-03-26 | 2004-10-07 | Janet Elizabeth Williams | Personal safety device |
US20050053968A1 (en) | 2003-03-31 | 2005-03-10 | Council Of Scientific And Industrial Research | Method for storing information in DNA |
US20100285985A1 (en) | 2003-04-15 | 2010-11-11 | Applied Dna Sciences, Inc. | Methods and Systems for the Generation of Plurality of Security Markers and the Detection Therof |
US20050112610A1 (en) | 2003-04-16 | 2005-05-26 | Applied Dna Sciences, Inc. | System and method for marking textiles with nucleic acids |
US20090042191A1 (en) | 2003-04-16 | 2009-02-12 | Hayward James A | System and method for secure document printing and detection |
US20080293052A1 (en) | 2003-04-16 | 2008-11-27 | Ming-Hwa Liang | System and method for authenticating sports identification goods |
US20090075261A1 (en) | 2003-04-16 | 2009-03-19 | Hayward James A | System and method for authenticating tablets |
US20080299559A1 (en) | 2003-04-16 | 2008-12-04 | Thomas Kwok | Methods for authenticating articles with optical reporters |
US20070121937A1 (en) | 2003-06-26 | 2007-05-31 | Kochevar Peter D | Site-specific access management |
US20050059059A1 (en) | 2003-08-06 | 2005-03-17 | Benjamin Liang | Novel nucleic acid based steganography system and application thereof |
US7732492B2 (en) | 2003-08-08 | 2010-06-08 | Ajinomoto Co., Inc. | Nateglinide-containing preparation |
US20080149713A1 (en) | 2003-08-13 | 2008-06-26 | Brundage Trent J | Detecting Media Areas Likely of Hosting Watermarks |
US20070026239A1 (en) | 2003-08-26 | 2007-02-01 | Csem Centre Suisse D-Electronique Et De Microtechique Sa | Functionalization of yarn and textile products |
US20050142565A1 (en) | 2003-12-30 | 2005-06-30 | Agency For Science, Technology And Research | Nucleic acid purification chip |
WO2005103226A2 (en) | 2004-03-24 | 2005-11-03 | Wisconsin Alumni Research Foundation | Plasma-enhanced functionalization of inorganic oxide surfaces |
US20050260609A1 (en) | 2004-05-24 | 2005-11-24 | Lapidus Stanley N | Methods and devices for sequencing nucleic acids |
US20060017959A1 (en) | 2004-07-06 | 2006-01-26 | Downer Raymond J | Document classification and authentication |
US20070254292A1 (en) | 2004-08-20 | 2007-11-01 | Asahi Kasei Kabushiki Kaisha | Method for Trapping Nucleic Acids Using Divalent Metal Ions |
US20060199196A1 (en) | 2004-11-05 | 2006-09-07 | Invitrogen Corporation | Compositions and methods for using radio frequency identifiers in biological sciences |
US20090253127A1 (en) | 2004-11-17 | 2009-10-08 | Forensink Corporation Inc. | Compositions for Marking Objects with DNA and Methods for Marking and Linking an Object to its Owner |
US20060117465A1 (en) | 2004-12-03 | 2006-06-08 | Willows Keith S | Number/bib holder |
US20120115154A1 (en) | 2004-12-23 | 2012-05-10 | Greg Hampikian | Reference markers for biological samples |
US20060286569A1 (en) | 2005-03-10 | 2006-12-21 | Bar-Or Yuval A | Method, apparatus, and system for authentication using labels containing nucleotide sequences |
US20090311555A1 (en) | 2005-04-15 | 2009-12-17 | Surface Innovations Ltd. | Methof for Producing a Thiol Functionalised Coating |
WO2006109014A1 (en) | 2005-04-15 | 2006-10-19 | University Of Durham | Thiol functionalised coatings and method for producing the same |
US20070048761A1 (en) | 2005-05-20 | 2007-03-01 | Applied Dna Sciences, Inc. | System and method for authenticating multiple components associated with a particular product |
US20070012784A1 (en) | 2005-06-20 | 2007-01-18 | Mercolino Thomas J | Product authentication |
US20080216255A1 (en) | 2005-09-17 | 2008-09-11 | Robert Lee Poovey | Textile Marker Application Method and Textiles Produced therefrom |
US20070072197A1 (en) | 2005-09-28 | 2007-03-29 | Rayms-Keller Alfredo N | Microtags for detection and identification of materials |
JP2009517250A (en) | 2005-11-30 | 2009-04-30 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Laser transfer of security function |
WO2007078833A2 (en) | 2005-12-16 | 2007-07-12 | The Curators Of The University Of Missouri | Reusable pcr amplification system and method |
US20090220789A1 (en) | 2006-01-27 | 2009-09-03 | The University Of North Carolina At Chapel Hill | Taggants and methods and systems for fabricating same |
GB2434570A (en) | 2006-01-31 | 2007-08-01 | Alexander Peter Mackay | Applying DNA as an item label |
US7250195B1 (en) | 2006-02-27 | 2007-07-31 | Ionic Fusion Corporation | Molecular plasma deposition of colloidal materials |
EP1847316A1 (en) | 2006-04-19 | 2007-10-24 | Eppendorf Array Technologies SA (EAT) | Method for stabilizing functional groups on a surface of a polymer used as solid support for making microarrays |
US20090286250A1 (en) | 2006-05-19 | 2009-11-19 | James Arthur Hayward | Incorporating soluble security markers into cyanoacrylate solutions |
WO2008007060A1 (en) | 2006-07-08 | 2008-01-17 | Redweb Security (Uk) Limited | Marking material |
US20080045288A1 (en) | 2006-08-17 | 2008-02-21 | Waterleaf Limited | Method and System for Indicating a Jackpot Payout Expectancy for a Game |
US20080081357A1 (en) | 2006-09-29 | 2008-04-03 | Samsung Electronics Co., Ltd. | Method and apparatus for isolating nucleic acids from a cell using carbon nanotubes and silica beads |
US8278807B2 (en) | 2006-10-17 | 2012-10-02 | Renault S.A.S. | Radiofrequency plasma generation device |
US20080153135A1 (en) | 2006-12-20 | 2008-06-26 | Liu Timothy Z | Methods and apparatus for conducting amplification reactions on high density hydrophilic patterned microplates |
US20100285490A1 (en) | 2006-12-29 | 2010-11-11 | Invitrogen Corporation | Detection apparatus |
WO2008154931A1 (en) | 2007-06-18 | 2008-12-24 | Danmarks Tekniske Universitet (Technical University Of Denmark) | Adsorbent beads suitable for use in separation of biological molecules |
US20090069199A1 (en) | 2007-07-16 | 2009-03-12 | Albrecht Brandenburg | Method and device for optical detection of substances in a liquid or gaseous medium |
US20090136163A1 (en) | 2007-08-02 | 2009-05-28 | George Scott Kerr | Bag and article of manufacture |
US20150125949A1 (en) | 2007-11-30 | 2015-05-07 | Geneart Ag | Steganographic embedding of information in coding genes |
US20110014133A1 (en) * | 2008-02-14 | 2011-01-20 | Grunstein Michael M | Compositions and Methods to Treat Asthma |
US20090222912A1 (en) | 2008-02-29 | 2009-09-03 | Boschin Luigi | Identification device and authentication method through such a device |
US20110263688A1 (en) | 2008-04-09 | 2011-10-27 | Purdue Research Foundation | Coferons and methods of making and using them |
US20100050344A1 (en) | 2008-08-28 | 2010-03-04 | Dirty Laundry, Llc | Laundry stain and soil pretreatment sheet |
US20110229881A1 (en) | 2008-09-11 | 2011-09-22 | Nagahama Bio-Laboratory Incorporated | Dna-containing ink composition |
US20100075407A1 (en) | 2008-09-23 | 2010-03-25 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
US20110250594A1 (en) | 2008-11-12 | 2011-10-13 | Ming-Hwa Liang | Methods for genetic analysis of textiles made of gossypium barbadense and gossypium hirsutum cotton |
US20100149531A1 (en) | 2008-12-13 | 2010-06-17 | Allegro Asia Technology (Hk) Ltd. | Apparatus and method for object authentication using taggant material |
WO2010075858A2 (en) | 2009-01-05 | 2010-07-08 | Synthesechemie Dr. Penth Gmbh | Measuring machine and method for detecting the content of oil, hydrocarbons, and oxidizable gases in air or compressed air |
US20100240101A1 (en) | 2009-03-19 | 2010-09-23 | Massachusetts Institute Of Technology | Parallel Proximity Ligation Event Analysis |
US20100250616A1 (en) | 2009-03-24 | 2010-09-30 | Kim Richard C | Memorabilia registry system |
US20100258743A1 (en) | 2009-04-13 | 2010-10-14 | Src, Inc. | Location Analysis Using Nucleic Acid-Labeled Tags |
US20100285447A1 (en) | 2009-05-07 | 2010-11-11 | Biomerieux, Inc. | Methods for Antimicrobial Resistance Determination |
US20100307120A1 (en) | 2009-06-05 | 2010-12-09 | Stover Jimmy R | Harvester with heated duct |
US20110054938A1 (en) | 2009-08-28 | 2011-03-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Devices and methods for detecting an analyte in salivary fluid |
US20120264742A1 (en) | 2009-11-12 | 2012-10-18 | Nippon Zoki Pharmaceutical Co., Ltd. | Pharmaceutical composition for external use |
US20110165569A1 (en) | 2010-01-07 | 2011-07-07 | Jeansee Llc | Combinatorial dna taggants and methods of preparation and use thereof |
EP2428925A1 (en) | 2010-08-27 | 2012-03-14 | JT International | Product authentication method |
EP2444546A1 (en) | 2010-10-20 | 2012-04-25 | Centro Tessile Cotoniero e Abbigliamento S.p.A. | Method for biomarking textile materials |
EP2444136A1 (en) | 2010-10-22 | 2012-04-25 | Bandit NV | A fog generator comprising a fog generating marker fluid |
WO2012076021A1 (en) | 2010-12-10 | 2012-06-14 | Nkt Photonics A/S | An acousto-optical tunable filter (aotf) for a broad band source for fluorescence measurement system |
US20130040150A1 (en) | 2011-08-10 | 2013-02-14 | The Johns Hopkins University | Nanoparticle Taggants for Explosive Precursors |
US20130046994A1 (en) | 2011-08-17 | 2013-02-21 | Harry C. Shaw | Integrated genomic and proteomic security protocol |
US20130048731A1 (en) | 2011-08-25 | 2013-02-28 | International Business Machines Corporation | System for recovering a barcode |
US20130109596A1 (en) | 2011-09-26 | 2013-05-02 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
WO2013052924A1 (en) | 2011-10-06 | 2013-04-11 | AI Cure Technologies, Inc. | Method and apparatus for fractal identification |
US20150133319A1 (en) | 2012-02-27 | 2015-05-14 | Cellular Research, Inc. | Compositions and kits for molecular counting |
US20130234043A1 (en) | 2012-03-09 | 2013-09-12 | United States Postal Service | Method and system for item authentication and customization |
US20150030545A1 (en) | 2012-03-26 | 2015-01-29 | Eth Zurich | Molecular code systems |
US20130274129A1 (en) | 2012-04-04 | 2013-10-17 | Geneart Ag | Tal-effector assembly platform, customized services, kits and assays |
WO2013154943A1 (en) | 2012-04-09 | 2013-10-17 | Applied Dna Sciences, Inc. | Plasma treatment for dna binding |
US20160326511A1 (en) | 2012-04-09 | 2016-11-10 | Apdn (B.V.I.) Inc. | Plasma treatment for dna binding |
US20150083797A1 (en) | 2012-05-09 | 2015-03-26 | Apdn (B.V.I.) Inc. | Verification of physical encryption taggants using digital representatives and authentications thereof |
WO2013170009A1 (en) | 2012-05-09 | 2013-11-14 | Applied Dna Sciences, Inc. | Verification of physical encryption taggants uning digital representatives and authentications thereof |
US20150107475A1 (en) | 2012-10-10 | 2015-04-23 | Apdn (B.V.I.) Inc. | Dna marking of previously undistinguished items for traceability |
US20140099643A1 (en) | 2012-10-10 | 2014-04-10 | Applied Dna Sciences, Inc. | Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings |
US9266370B2 (en) | 2012-10-10 | 2016-02-23 | Apdn (B.V.I) Inc. | DNA marking of previously undistinguished items for traceability |
US9297032B2 (en) | 2012-10-10 | 2016-03-29 | Apdn (B.V.I.) Inc. | Use of perturbants to facilitate incorporation and recovery of taggants from polymerized coatings |
WO2014062754A1 (en) | 2012-10-16 | 2014-04-24 | Applied Dna Sciences, Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
US20140106357A1 (en) | 2012-10-16 | 2014-04-17 | Applied Dna Sciences, Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
US20140224673A1 (en) | 2013-02-08 | 2014-08-14 | Board Of Trustees Of Michigan State University | Nanoparticle-serialized oligonucleotide methods, compositions, and articles |
US20140256881A1 (en) | 2013-03-07 | 2014-09-11 | Applied Dna Sciences, Inc. | Alkaline activation for immobilization of dna taggants |
US20150018538A1 (en) | 2013-03-07 | 2015-01-15 | Applied Dna Sciences, Inc. | Method and device for marking articles |
US20140272097A1 (en) | 2013-03-12 | 2014-09-18 | Applied Dna Sciences, Inc. | Dna marking of previously undistinguished items for traceability |
US20160168781A1 (en) | 2014-12-16 | 2016-06-16 | Apdn (B.V.I.) Inc. | Method and device for marking fibrous materials |
Non-Patent Citations (64)
Title |
---|
"Fish" (Wikipedia.com; accessed Nov. 2, 2014). |
"Fungi" (Wikipedia.com; accessed Jun. 3, 2013). |
"How many species of bacteria are there" (wisegeek.com; accessed Jan. 21, 2014). |
"List of sequenced bacterial genomes" (Wikipedia.com; accessed Jan. 24, 2014). |
"Mammal" (Wikipedia.com; accessed Sep. 22, 2011). |
"Murinae" (Wikipedia.com; accessed Sep. 22, 2011). |
"Plant" (Wikipedia.com; accessed Mar. 8, 2013). |
"Virus" (Wikipedia.com, accessed Nov. 24, 2012). |
Agrawal & Tang, "Site-specific functionalization of oligodoexynucleotides for non-radioactive labelling." Tetrahedron Letters, vol. 31, pp. 1543-1546 (1990) Pergamon Press, Great Britain. |
Aleksandr Ovsianikov et al., "Two-photon Polymerization Technique for Microfabrication of CAD-designed 3D Scaffolds from Commercially Available Photosensitive Materials," Journal of Tissue Engineering and Regenerative Medicine, vol. 1, No. 6, Nov. 10, 2007, pp. 443-449, XP055308966. |
ALEKSANDR OVSIANIKOV, SABRINA SCHLIE, ANACLET NGEZAHAYO, AXEL HAVERICH, BORIS N. CHICHKOV: "Two-photon polymerization technique for microfabrication of CAD-designed 3D scaffolds from commercially available photosensitive materials", JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, JOHN WILEY & SONS, US, vol. 1, no. 6, 1 November 2007 (2007-11-01), US, pages 443 - 449, XP055308966, ISSN: 1932-6254, DOI: 10.1002/term.57 |
Beija, Mariana; et al. Synthesis and applications of Rhodamine derivatives as fluorescent probes (2009) Critical Reviews, vol. 38: pp. 2410-2433. Chemical Society Reviews; Advance article published on the web Apr. 27, 2009. |
Berger et al., "Flow in Curved Pipes," Ann. Rev. Fluid Mech, v. 15, 1983, pp. 461-512. |
Chrisey et al., "Fabrication of Patterned DNA Surfaces," Nucleic Acids Research, Information Retrieval Ltd, GB, vol. 24, No. 15, Jan. 1, 1996, pp. 3040-3047, XP002913337. |
CHRISEY L. A., ET AL.: "FABRICATION OF PATTERNED DNA SURFACES.", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD., vol. 24., no. 15., 1 January 1996 (1996-01-01), pages 3040 - 3047., XP002913337, ISSN: 0305-1048, DOI: 10.1093/nar/24.15.3040 |
Corstjens, et al. "Infrared Up-converting phosphors for bioassays." IEE Proceedings-Nanobiotechnology, vol. 152, pp. 64-72 (2005) Institution of Engineering and Technology, London. |
Curcio et al., "Continuous Segmented-Flow Polymerase Chain Reaction for High-Throughput Miniaturized DNA Amplification," Analytical Chemistry, vol. 75, No. 1, Jan. 1, 2003, pp. 1-7. |
F FIXE, FABER A, GON�ALVES D, PRAZERES D.M.F, CABE�A R, CHU V, FERREIRA G, CONDE J.P: "Thin film micro arrays with immobilized DNA for hybridization analysis", MRS ONLINE PROCEEDINGS, CAMBRIDGE UNIVERSITY PRESS, US, vol. 723, 1 January 2002 (2002-01-01), US, pages O2.3.1 - O2.3.6, XP055308987, ISSN: 1946-4274, DOI: 10.1557/PROC-723-O2.3 |
F. Fixe et al., "Thin Film Micro Arrays with Immobilized DNA for Hybridization Analysis," MRS Online Proceedings, vol. 723, Jan. 1, 2002, XP055308987. |
Gibson, et al. "A Novel Method for Real Time Quantitative RT-PCR" Genome Research, vol. 6, pp. 995-1001 (1996) Cold Spring Harbor Laboratory Press, Woodbury, New York. |
Gupta, et al. "A general method for the synthesis of 3′-sulfhydryl and phosphate group containing oligonucleotides." Nucleic Acids Research, vol. 19, pp. 3019-3025 (1991) Oxford University Press, Oxford, England. |
Hashimoto, Masahiko et al., "Rapid PCR in a Continuous Flow Device", Lab Chip, 4, 638-645 (2004). |
Holland, et al. "Detection of specific polymerase chain reaction product by utilizing the 5′ [to] 3′ exonuclease activity of Thermus aquaticus DNA polymerase." Proceedings of the National Academy of Sciences, USA vol. 86 pp. 7276-7280 (1991) National Academy of Sciences, Washington, DC. |
Hosokawa, K. et al. DNA Detection on a power-free microchip with laminar flow-assisted dendritic amplification. Analytical Sciences, 2010, Vo. 26, No. 10, pp. 1052-1057. |
Hussein et al. "Molecular Characterization of Cotton Genotypes Using PCR-based Markers." Journal of Applied Sciences Research 3(10) 1156-1169 (2007). INSInet Publication. |
Ibrahim, et al. Complete nucleotide sequence of the cotton (Gossypium barbadense L.) chloroplast genome with a comparative analysis of sequence among 9 dicot plants. Genes and Genetic Systems vol. 81. pp. 311-321 (2006). |
Instant Krazy Glue, product description, accessed website Feb. 24, 2012, 4 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2013/065161 dated Apr. 21, 2015. |
Jiang, et al. "Polyploid formatioopn created unique avenues for response to selection in Gossypium (cotton)" Proceedings of the National Academy of Sciences, USA vol. 95 pp. 4419-4424 (1998) National Academy of Sciences, Washington, DC. |
Jim Hayward et al., "A Scaled, Integrative Implementation for DNA Marking of Integrated Circuits," Apr. 18, 2013, XP055308145, URL: http://www.erai.com/CustomUploads/conference/2013/PDF/APDNAApril18.pdf. |
JIM HAYWARD, JANICE MERAGLIA, BOB MACDOWELL: "A Scaled, Integrative Implementation for DNA Marking of Integrated Circuits", 18 April 2013 (2013-04-18), XP055308145, Retrieved from the Internet <URL:http://www.erai.com/CustomUploads/conference/2013/PDF/APDNAApril18.pdf> |
Kaneda, S. et al. Modification of the glass surface property in PDMS-glass hybrid microfluidoc devces. Analytical Sciences, Jan. 2012, vol. 28, No. 1, pp. 39-44. |
Karahan et al., Fibers and Polymers, vol. 9, pp. 21-26 (2008). |
KHANDJIAN E W: "OPTIMIZED HYBRIDIZATION OF DNA BLOTTED AND FIXED TO NITROCELLULOSE AND NYLON MEMBRANES", BIOTECHNOLOGY. THE INTERNATIONAL MONTHLY FOR INDUSTRIAL BIOLOGY, NATURE PUBLISHING GROUP, US, vol. 5, no. 2, 1 January 1987 (1987-01-01), US, pages 165 - 167, XP002762699, ISSN: 0733-222X |
Khandjian, "Optimized Hybridization of DNA Blotted and Fixed to Nitrocellulose and Nylon Membranes," Bio-Technology (New York), vol. 5, No. 2, 1987, pp. 165-167, XP002762699. |
Kim et al., "Fabrication and characterization of a PDMS-glass hybrid continuous-flow PCR chip," Biochemical Engineering Journal, 2006, vol. 29, pp. 91-97. |
Kopp et al., "Chemical Amplification: Continuous-Flow PCR on a Chip," Science, vol. 280, May 15, 1998, pp. 1046-1048. |
Lee, et al. "Allelic discrimination by nick translation PCR with fluorescent probes." Nucleic Acids Research, vol. 21, pp. 3761-3766 (1993) Oxford University Press, Oxford, England. |
Lee, et al. "The complete genome sequence of Gossypium hursutum, organization and phylogenetic relationships to ether angiosperms." BMC Genomics 7:61, Mar. 2006. |
M. Ageno, E. Dore and C. Frontali The Alkaline Denaturation of DNA, Biophys. J. Nov. 1969, 9(11): 1281. Abstract. |
M. Ageno, E. Dore and C. Frontali The Alkaline Denaturation of DNA, Biophys. J. Nov. 1969, 9(11): 1281-1311. |
Nazarenko, et al. "A closed tube format for amplification and detection of DNA based on energy transfer," Nucleic Acids Research, vol. 25, pp. 2516-2521 (1997) Oxford University Press. |
Nelson, "Bifunctional oligonucleotide probes synthesized using a novel CPG support are able to detect single base pair mutations." Nucleic Acids Research, vol. 17, pp. 7187-7194 (1989) IRL Press Limited, Oxford. |
Obeid, Pierre J. et al., "Microfabricated Device for DNA and RNA Amplification by Continuous-Flow Polymerase Chain Reaction and Reverse Transcription-Polymerase Chain Reaction with Cycle Number Section", Anal. Chem, 75, 288-295 (2003). |
Park, H. et al. Stress response of fibroblasts adherent to the surface of plasma-treated poly(lactic-co-glucolic acid) nanofiber matrices. Colloids surf B Biointerfaces, May 2010, 1; 77(1):90-95. |
Reid, et al. "Real Time Quantitative PCR." Genome Research, vol. 6, pp. 986-994 (1996) Cold Spring Harbor Laboratory Press, Woodbury, New York. |
S. Hou, X. Li and X-Z Feng Method to improve DNA Condesation Efficiency by Alkali Treatment. Nucleosides, Nucleotides and Nucleic Acids, 2009. 28:725-735.Taylor & Francis Group, LLC. |
Schulz et al., "Archived or directly swabbed latent fingerprints as a DNA source for STR typing," Forensic Science International, 127 (2002) 128-130. |
Skirtach et al., "The Role of Metal Nanoparticles in Remote Release of Encapsulated Materials," Nano Letters, vol. 5, No. 7, 2005, pp. 1371-1377. |
Sproat, et al. "The synthesis of protected 5′-mercapto-2′,5′-didoexyribonucleoside-3-O-phosphoramidites, uses of 5′-mercapto-didoexyribonucleosides." Nucleic Acids Research, vol. 15, pp. 4837-4848 (1987) IRL Press Limited, Oxford. |
Supplementary European Search Report for Corresponding European Application No. EP14820538, pp. 1-8. |
T. Thiel, L. Liczkowski and S.T. Bissen New zwitterionic butanesulfonic acids that extend the alkaline range of four families of good buffers: Evaluation for use in biological Systems. J. Biochem. Biophys. Methods (1998) 37: 117-129. Elsevier. |
Takara Bio, "Takara Bio to Produce DNA Fragments for DNA Microarrays on Industrial Scale", http://www.evaluategroup.com/Universal/View.aspx?type_Story&id. |
Tuzlakoglu K. et al. A new route to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation. J Biomed Mater Res A, Jan. 2010, 92(1):369-377. |
Tyagi & Kramer, "Molecular Beacons: Probes that Fluoresce upon Hybridization" nature Biotechnology, vol. 14, pp. 303-308 (1996) Nature Publishing Group, New York. |
Tyagi, et al. Multicolor molecular beacons for allele discrimination, Nature Biotechnology, vol. 16, pp. 49-53 (1998) Nature Publishing Group, New York. |
Ullrich, T. et al. Competitive reporter monitored amplification (CMA)-quantification of molecular targets by real time monitoring of competitive reporter hybridization. PLoS One, 2012, vol. 7, No. 4 E35438. doi;I0.1371/journal.pone.0035438, p. 1-13. |
Van Der Rijke, et al. "Up-converting phosphor reporters for nucleic acid microarrays." Nature Biotechnology, vol. 19, pp. 273-276 (2001) Nature Publishing Group, New York. |
Versalift, "Market Growth, the evolution of the aerial lift industry," Oct. 1, 2002. Accessed on web Nov. 10, 2008. |
Whitcombe, et al. "Detection of PCR products using self-probing amplicons and fluorescence," Nature Biotechnology, vol. 17 pp. 804-807 (1999) Nature America, Inc. New York. |
Written Opinion of the International Search Authority for PCT/US15/21165 dated Jul. 2, 2015. |
Written Opinion of the International Search Authority for PCT/US2015/013084 dated Apr. 17, 2015. |
Yang, X.F. et al. Fluorometric determination of hemoglobin using spiro form rhodamine B hydrazide in a micellar medium, Tantala, vol. 62(4):439-445; Nov. 12, 2003. |
Zuckermann, et al. "Efficient methods for attachment of thiol specific probes to the 3′ end of synthetic oligonucleotides." Nucleic Acids Research, vol. 15, pp. 5305-5321 (1987) IRL Press Limited, Oxford. |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11691165B2 (en) | 2011-10-27 | 2023-07-04 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
US10921484B2 (en) * | 2017-11-21 | 2021-02-16 | Reliance Core Consulting | Methods and systems for detecting motion corresponding to a field of interest |
Also Published As
Publication number | Publication date |
---|---|
US20150302713A1 (en) | 2015-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013331402B2 (en) | Security system and method of marking an inventory item and/or person in the vicinity | |
US10741034B2 (en) | Security system and method of marking an inventory item and/or person in the vicinity | |
US9919512B2 (en) | DNA marking of previously undistinguished items for traceability | |
US9309555B2 (en) | Location analysis using fire retardant-protected nucleic acid-labeled tags | |
US20150141264A1 (en) | In-field dna extraction, detection and authentication methods and systems therefor | |
US20070048761A1 (en) | System and method for authenticating multiple components associated with a particular product | |
US8415165B2 (en) | System and method for authenticating sports identification goods | |
US8420400B2 (en) | System and method for authenticating tablets | |
US5763176A (en) | Methods and devices for marking a solid and subsequently detecting the markings | |
US20160102215A1 (en) | Incorporating soluble security markers into cyanoacrylate solutions | |
US20140272097A1 (en) | Dna marking of previously undistinguished items for traceability | |
US9845503B2 (en) | Nucleic acid-labeled tags associated with odorant | |
CA2959312A1 (en) | In-field dna extraction, detection and authentication methods and systems therefor | |
KR20140071914A (en) | Use of diatomaceous earth as the base substrate for nucleic acid tags | |
GB2513936A (en) | System and method for rapid detection and identification of nucleic acid labeled tags | |
TW201634699A (en) | In-field DNA extraction, detection and authentication methods and systems therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: APDN (B.V.I.) INC., VIRGIN ISLANDS, BRITISH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BERRADA, ABDELKRIM;LIANG, MINGHWA BENJAMIN;JUNG, LAWRENCE;SIGNING DATES FROM 20150330 TO 20150407;REEL/FRAME:035458/0678 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: DELAWARE TRUST COMPANY, DELAWARE Free format text: SECURITY INTEREST;ASSIGNOR:APDN (B.V.I.) INC.;REEL/FRAME:048460/0095 Effective date: 20181019 Owner name: DELAWARE TRUST COMPANY, DELAWARE Free format text: SECURITY INTEREST;ASSIGNOR:APDN (B.V.I.) INC.;REEL/FRAME:048460/0160 Effective date: 20190226 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: APDN (B.V.I.) INC., NEW YORK Free format text: SECURITY INTEREST;ASSIGNOR:DELAWARE TRUST COMPANY;REEL/FRAME:054047/0148 Effective date: 20201009 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |